CASEID,PRIMARYID,CASEVERSION,I_F_CODE,EVENT_DT,MFR_DT,INIT_FDA_DT,FDA_DT,REPT_COD,AUTH_NUM,MFR_NUM,MFR_SNDR,LIT_REF,AGE,AGE_COD,AGE_GRP,SEX,E_SUB,WT,WT_COD,REPT_DT,TO_MFR,OCCP_COD,REPORTER_COUNTRY,OCCR_COUNTRY,DRUGNAME,PT,PRIMARYID_OUTC,OUTC_COD,PRIMARYID_RPSR,RPSR_COD,PRIMARYID_THER,DSG_DRUG_SEQ,START_DT,END_DT,DUR,DUR_COD,PRIMARYID_INDI,INDI_DRUG_SEQ,INDI_PT
10148859,101488593,3,F,201007,20210615,20140502,20210623,EXP,,CA-009507513-1404CAN014456,MERCK,,44,YR,,M,Y,,,20210623,,CN,CA,CA,EFAVIRENZ.,Asthenia;Drug interaction;Dysarthria;Gait disturbance;Slow speech;Somnolence,101488593,HO,,,101488593,1,200710,200810,,,101488593,1,HIV infection
10719292,107192925,5,F,,20210429,20150119,20210506,EXP,,CA-ROCHE-1522743,ROCHE,,54,YR,,M,Y,,,20210506,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,107192925,OT,,,,,,,,,107192925,1,Bipolar disorder
11465428,114654283,3,F,,20210430,20150907,20210514,EXP,,CA-ROCHE-1630210,ROCHE,,54,YR,,M,Y,,,20210514,,HP,COUNTRY NOT SPECIFIED,CA,SUSTIVA,Depression;Drug interaction,114654283,DE,,,,,,,,,114654283,1,Bipolar disorder
11520454,115204542,2,F,,20210614,20150918,20210627,EXP,,GB-AUROBINDO-AUR-APL-2015-08151,AUROBINDO,,63,YR,,M,Y,,,20210627,,HP,GB,GB,EFAVIRENZ.,Axonal neuropathy;Blood creatine phosphokinase increased;Mitochondrial myopathy;Myalgia,115204542,OT,,,,,,,,,115204542,1,Antiretroviral therapy
12741534,127415349,9,F,,20210331,20160914,20210403,EXP,,CA-ROCHE-1829817,ROCHE,,54,YR,,M,Y,,,20210403,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,127415349,OT,,,,,,,,,127415349,1,Product used for unknown indication
12810571,128105712,2,F,,20210517,20161005,20210525,EXP,,CA-APOTEX-2016AP012493,APOTEX,,,,,M,Y,,,20210525,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,128105712,HO,,,,,,,,,128105712,1,Product used for unknown indication
13906408,1390640818,18,F,,20210623,20170825,20210625,EXP,,CA-009507513-0809CAN00001,MERCK,,54,YR,,M,Y,,,20210625,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,1390640818,DE,,,1390640818,1,20070620,,,,1390640818,1,HIV infection
14301231,143012313,3,F,,20210517,20171219,20210525,EXP,,CA-APOTEX-2017AP022577,APOTEX,,,,,M,Y,,,20210525,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction,143012313,HO,,,,,,,,,143012313,1,Product used for unknown indication
14306973,143069739,9,F,,20210517,20171220,20210527,EXP,,CA-APOTEX-2017AP022582,APOTEX,,54,YR,,M,Y,,,20210527,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Loss of personal independence in daily activities,143069739,OT,,,,,,,,,143069739,1,Bipolar disorder
14307055,143070555,5,F,,20210517,20171220,20210527,EXP,,CA-APOTEX-2017AP022586,APOTEX,,,,,M,Y,,,20210527,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction,143070555,OT,,,,,,,,,143070555,1,Product used for unknown indication
14366162,143661623,3,F,,20210609,20180109,20210611,EXP,,CA-009507513-1801CAN001991,MERCK,,,,,,Y,,,20210611,,HP,CA,CA,EFAVIRENZ.,Acute kidney injury;Alanine aminotransferase increased;Anaemia;Aspartate aminotransferase increased;Blood bilirubin increased;Cerebral ischaemia;Cystitis noninfective;Drug interaction;Febrile neutropenia;Haematuria;Infection;Myalgia;Pulmonary embolism;Seizure;Thrombosis;Tumour lysis syndrome;Vomiting,143661623,OT,,,,,,,,,143661623,1,HIV infection
14652614,146526147,7,F,,20210603,20180319,20210615,EXP,,CA-APOTEX-2018AP007741,APOTEX,,44,YR,,M,Y,,,20210615,,CN,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,146526147,HO,,,,,,,,,146526147,1,Psychotic disorder
15626751,1562675114,14,F,,20210615,20181116,20210618,EXP,,CA-ABBVIE-18S-028-2552613-00,ABBVIE,,54,YR,,M,Y,,,20210618,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,1562675114,OT,,,,,,,,,1562675114,1,HIV infection
15656399,156563993,3,F,2001,20210427,20181126,20210429,EXP,,US-GILEAD-2018-0375976,GILEAD,,,,A,M,Y,68.03,KG,20210429,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Depression;Disability;Economic problem;Emotional distress;Multiple fractures;Osteoporosis;Pain;Renal failure;Renal impairment;Tooth loss;Visual acuity reduced,156563993,OT,,,156563993,1,2004,2014,,,156563993,1,Product used for unknown indication
15656583,156565833,3,F,20150506,20210430,20181126,20210505,EXP,,US-GILEAD-2018-0376057,GILEAD,,67,YR,E,F,Y,91.61,KG,20210505,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Economic problem;Emotional distress;Lower limb fracture;Multiple fractures;Osteopenia;Osteoporosis;Pain;Wrist fracture,156565833,OT,,,156565833,1,200601,20171008,,,156565833,1,HIV infection
15702258,157022582,2,F,,20210610,20181209,20210622,EXP,,PT-AUROBINDO-AUR-APL-2018-058726,AUROBINDO,,32,YR,,M,Y,,,20210622,,HP,PT,PT,EFAVIRENZ.,Drug-induced liver injury;Hepatic fibrosis;Transaminases increased,157022582,OT,,,,,,,,,157022582,1,Hepatitis C
15865337,158653372,2,F,20110825,20210614,20190124,20210624,EXP,,FR-AUROBINDO-AUR-APL-2019-002782,AUROBINDO,,37,YR,,M,Y,,,20210624,,HP,FR,FR,EFAVIRENZ.,Drug resistance;Viral mutation identified,158653372,OT,,,,,,,,,158653372,1,HIV infection
15897533,158975332,2,F,,20210507,20190131,20210517,EXP,,PT-009507513-1901PRT011858,MERCK,"FRAGOSO J, MENDEZ J, GUERRA D, TAVARES A P, ABREU M, GONCALVES M J. EVALUATION OF THE POPULATION OF COINFECTED HCV/HIV PATIENT NON RESPONDANT TO DAAS. PAPER PRESENTED AT THE 13TH REUNIAO NACIONAL DE COINFECAO VIH/HEPATITES. 2019",43,YR,,M,Y,,,20210517,,MD,PT,PT,EFAVIRENZ.,Hepatitis C;Treatment failure,158975332,OT,,,,,,,,,158975332,1,Hepatitis C
16011638,160116384,4,F,,20210524,20190227,20210527,EXP,,PT-ROCHE-2272243,ROCHE,MENDEZ J. EVALUATION OF THE POPULATION OF COINFECTED HCV/HIV PATIENT NON RESPONDANT TO DAAS.. PRESENTED AT CO?INFECTION PORTUGUESE STUDY GROUP. 2019?:?.,43,YR,,M,Y,,,20210527,,MD,PT,PT,EFAVIRENZ.,Hepatitis C;Treatment failure,160116384,OT,,,,,,,,,160116384,1,Hepatitis C
16025998,160259984,4,F,,20210519,20190302,20210601,EXP,,PT-AUROBINDO-AUR-APL-2019-011083,AUROBINDO,"MENDEZ,J. EVALUATION OF THE POPULATION OF COINFECTED HCV/HIV PATIENT NON RESPONDANT TO DAAS. PRESENTED AT CO?INFECTION PORTUGUESE STUDY GROUP. 2019?UNK:UNK",43,YR,,M,Y,,,20210601,,MD,PT,PT,Efavirenz Film Coated Tablets,Hepatitis C;Treatment failure,160259984,OT,,,,,,,,,160259984,1,HIV test positive
16032571,160325715,5,F,,20210405,20190304,20210415,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019003,BRISTOL MYERS SQUIBB,MENDEZ J. EVALUATION OF THE POPULATION OF COINFECTED HCV/HIV PATIENT NON RESPONDANT TO DAAS. PRESENTED AT CO?INFECTION PORTUGUESE STUDY GROUP. 2019,43,YR,,M,Y,,,20210415,,MD,PT,PT,EFAVIRENZ.,Hepatitis C;Treatment failure,160325715,OT,,,,,,,,,160325715,1,HIV test positive
16081150,1608115010,10,F,,20210325,20190316,20210405,EXP,,CA-AUROBINDO-AUR-APL-2019-013361,AUROBINDO,,54,YR,,M,Y,,,20210405,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,1608115010,DE,,,,,,,,,1608115010,1,HIV infection
16081155,160811557,7,F,,20210616,20190316,20210625,EXP,,CA-AUROBINDO-AUR-APL-2019-013363,AUROBINDO,,54,YR,,M,Y,,,20210625,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,160811557,OT,,,,,,,,,160811557,1,HIV infection
16306184,163061842,2,F,2010,20210510,20190513,20210518,EXP,,US-ASTRAZENECA-2019SE64125,ASTRAZENECA,,49,YR,,M,Y,,,20210518,,,US,US,SUSTIVA,Acute kidney injury;Chronic kidney disease;End stage renal disease;Renal failure,163061842,HO,,,163061842,1,201101,201205,,,163061842,1,Dyspepsia
16321127,163211275,5,F,20040608,20210622,20190516,20210629,EXP,,US-GILEAD-2019-0407768,GILEAD,,57,YR,A,M,Y,65.76,KG,20210629,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;Hyperparathyroidism secondary;Hyperphosphataemia;Nephropathy;Osteopenia;Pain;Proteinuria;Radius fracture;Wrist fracture,163211275,OT,,,163211275,1,200404,2005,,,163211275,1,HIV infection
16333090,163330903,3,F,20120412,20200714,20190520,20210514,PER,,US-GILEAD-2019-0407953,GILEAD,,42,YR,A,M,Y,111.11,KG,20210514,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Economic problem;Emotional distress;Pain;Proteinuria;Renal disorder;Renal impairment,163330903,OT,,,163330903,1,2007,20160407,,,163330903,1,HIV infection
16334713,163347136,6,F,2008,20210414,20190520,20210419,EXP,,US-GILEAD-2019-0408522,GILEAD,,59,YR,A,M,Y,75.7,KG,20210419,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Bone density decreased;Depression;Economic problem;Emotional distress;Fall;Femoral neck fracture;Gait disturbance;Osteomalacia;Osteopenia;Osteoporosis;Osteoporotic fracture;Pain;Scar;Tooth loss,163347136,DS,,,163347136,1,200402,201303,,,163347136,1,HIV infection
16338249,163382493,3,F,20120213,20210604,20190521,20210607,EXP,,US-GILEAD-2019-0408272,GILEAD,,50,YR,A,M,Y,62.59,KG,20210607,,CN,US,US,SUSTIVA,Acute kidney injury;Anaemia;Anhedonia;Anxiety;Chronic kidney disease;Depression;Economic problem;Emotional distress;End stage renal disease;Pain,163382493,OT,,,163382493,1,20090705,20120214,,,163382493,1,HIV infection
16439860,164398604,4,F,,20210609,20190617,20210616,EXP,,CA-009507513-1906CAN005466,MERCK,,,,,M,Y,,,20210616,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,164398604,DE,,,,,,,,,164398604,1,Product used for unknown indication
16470789,164707898,8,F,,20210517,20190624,20210524,EXP,,UG-MYLANLABS-2019M1058216,MYLAN,,,,,F,Y,3.7,KG,20210524,,HP,UG,UG,EFAVIRENZ/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE TABLETS,Congenital skin dimples;Congenital umbilical hernia;Foetal exposure during pregnancy,164707898,OT,,,164707898,1,20170721,20180614,,,164707898,1,HIV infection
16542961,165429613,3,F,,20210329,20190709,20210407,EXP,,CA-AUROBINDO-AUR-APL-2019-037761,AUROBINDO,,54,YR,,M,Y,,,20210407,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,165429613,OT,,,,,,,,,165429613,1,Product used for unknown indication
16589111,165891115,5,F,200801,20210623,20190718,20210630,EXP,,US-GILEAD-2019-0418470,GILEAD,,49,YR,A,M,Y,78.91,KG,20210630,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthritis;Bone density decreased;Bone loss;Economic problem;Emotional distress;Hydronephrosis;Nephrolithiasis;Osteoarthritis;Osteonecrosis;Osteopenia;Osteoporosis;Pain;Renal failure,165891115,OT,,,165891115,1,2001,2011,,,165891115,1,HIV infection
16590194,165901946,6,F,,20210409,20190718,20210419,EXP,,CA-TEVA-2018-CA-968075,TEVA,,44,YR,A,M,Y,,,20210419,,HP,CA,CA,SUSTIVA,Anxiety,165901946,OT,,,,,,,,,165901946,1,HIV infection
16647369,166473694,4,F,2009,20210622,20190730,20210628,EXP,,US-GILEAD-2019-0420236,GILEAD,,51,YR,A,M,Y,95.24,KG,20210628,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Chronic kidney disease;Dysuria;Economic problem;Emotional distress;End stage renal disease;Fatigue;Nephrolithiasis;Osteonecrosis;Pain;Renal failure;Tooth loss,166473694,OT,,,166473694,1,200608,201608,,,166473694,1,HIV infection
16653423,166534234,4,F,2013,20210628,20190731,20210630,EXP,,US-GILEAD-2019-0420315,GILEAD,,54,YR,A,M,Y,89.8,KG,20210630,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Depression;Economic problem;Emotional distress;Multiple fractures;Osteonecrosis;Pain;Patella fracture;Tooth loss,166534234,OT,,,166534234,1,20080715,20190215,,,166534234,1,HIV infection
16653524,166535244,4,F,201611,20210622,20190731,20210625,EXP,,US-GILEAD-2019-0420287,GILEAD,,60,YR,A,M,Y,72.56,KG,20210625,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Diabetic nephropathy;Economic problem;Emotional distress;End stage renal disease;Focal segmental glomerulosclerosis;Glomerulosclerosis;Intercapillary glomerulosclerosis;Kidney fibrosis;Pain;Renal arteriosclerosis;Renal failure,166535244,OT,,,166535244,1,200812,201511,,,166535244,1,HIV infection
16666980,166669804,4,F,200501,20210129,20190805,20210517,EXP,,US-GILEAD-2019-0421690,GILEAD,,40,YR,A,M,Y,83.9,KG,20210517,,LW,US,US,EFAVIRENZ.,Anhedonia;Anxiety;Appetite disorder;Asthenia;Back pain;Chronic kidney disease;Depression;Diarrhoea;Economic problem;Emotional distress;Night sweats;Pain;Pollakiuria;Rhinorrhoea;Weight decreased,166669804,OT,,,166669804,1,200601,201001,,,166669804,1,HIV infection
16678638,166786385,5,F,2015,20210617,20190807,20210624,EXP,,US-GILEAD-2019-0421720,GILEAD,,59,YR,A,F,Y,63.5,KG,20210624,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;Pain,166786385,OT,,,166786385,1,20100506,20160606,,,166786385,1,HIV infection
16745875,167458753,3,F,,20210517,20190827,20210524,EXP,PT-EMA-DD-20181218-KUMARVN_P-173122,PT-MYLANLABS-2019M1079394,MYLAN,"RAPOSO AF, ANTUNES AP, STRECHT T, ALVES SC, OLIVEIRA C, GUIMARAES M, ET AL... PHARMACOLOGICAL COMPLEXITY IN HIV?INFECTED PATIENTS. 23RD NATIONAL INTERNAL MEDICINE CONGRESS. 2017?23:1",49,YR,,M,Y,,,20210524,,HP,PT,PT,EFAVIRENZ.,Acute kidney injury;Hepatotoxicity;Tubulointerstitial nephritis,167458753,OT,,,,,,,,,167458753,1,HIV infection
16765373,167653734,4,F,20150829,20210617,20190903,20210624,EXP,,US-GILEAD-2019-0425747,GILEAD,,41,YR,A,M,Y,97.79,KG,20210624,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;End stage renal disease;Pain,167653734,OT,,,167653734,1,2012,2017,,,167653734,1,HIV infection
16765537,167655377,7,F,20131026,20210608,20190903,20210611,EXP,,US-GILEAD-2019-0425749,GILEAD,,51,YR,A,M,Y,74.39,KG,20210611,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Economic problem;Emotional distress;Hand fracture;Osteopenia;Pain;Tooth loss,167655377,OT,,,167655377,1,2014,2019,,,167655377,1,HIV infection
16774553,167745535,5,F,2018,20210601,20190905,20210603,EXP,,US-GILEAD-2019-0425688,GILEAD,,53,YR,A,M,Y,73.47,KG,20210603,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Economic problem;Emotional distress;Multiple injuries;Pain;Panic attack,167745535,OT,,,167745535,1,2011,201803,,,167745535,1,HIV infection
16774600,167746004,4,F,20180209,20210528,20190905,20210601,EXP,,US-GILEAD-2019-0425686,GILEAD,,54,YR,A,M,Y,72.56,KG,20210601,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Depression;Economic problem;Emotional distress;Hip fracture;Multiple injuries;Osteoporosis;Pain;Upper limb fracture,167746004,OT,,,167746004,1,201807,201901,,,167746004,1,HIV infection
16810270,168102705,5,F,20030814,20210621,20190916,20210624,EXP,,US-GILEAD-2019-0428371,GILEAD,,43,YR,A,M,Y,58.96,KG,20210624,,CN,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Blood creatinine increased;Bone density decreased;Bone loss;Chronic kidney disease;Depression;Economic problem;Emotional distress;End stage renal disease;Nephropathy;Osteonecrosis;Osteopenia;Pain;Proteinuria;Renal cell carcinoma;Renal cyst;Renal failure;Renal mass;Vitamin D deficiency,168102705,OT,,,168102705,1,20020801,20031110,,,168102705,1,HIV infection
16826328,168263287,7,F,20070215,20200928,20190919,20210407,EXP,,US-GILEAD-2019-0428473,GILEAD,,35,YR,A,M,Y,79.37,KG,20210407,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Chronic kidney disease;Depression;Economic problem;Emotional distress;Fanconi syndrome acquired;Femur fracture;Flank pain;Hip arthroplasty;Insomnia;Leukocyturia;Multiple fractures;Nephrolithiasis;Osteoarthritis;Osteomalacia;Osteonecrosis;Osteopenia;Osteoporosis;Pain;Post-traumatic stress disorder;Renal cyst;Renal failure;Rib fracture;Scapula fracture;Sternal fracture;Vitamin D deficiency,168263287,OT,,,168263287,1,20060725,20121203,,,168263287,1,HIV infection
16831229,168312295,5,F,20151126,20210623,20190920,20210628,EXP,,US-GILEAD-2019-0428481,GILEAD,,49,YR,A,M,Y,79.38,KG,20210628,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bone density decreased;Bone loss;Cervical vertebral fracture;Chronic kidney disease;Clavicle fracture;Economic problem;Emotional distress;Glomerular filtration rate decreased;Intervertebral disc protrusion;Osteoarthritis;Osteonecrosis;Pain;Renal failure;Rib fracture;Spinal osteoarthritis;Spinal stenosis,168312295,OT,,,168312295,1,2006,2016,,,168312295,1,HIV infection
16832947,168329474,4,F,20150625,20200831,20190920,20210407,EXP,,US-GILEAD-2019-0428480,GILEAD,,38,YR,A,F,Y,63.49,KG,20210407,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Economic problem;Emotional distress;Pain;Renal failure,168329474,OT,,,168329474,1,200610,201705,,,168329474,1,HIV infection
16834054,168340545,5,F,20080403,20210618,20190920,20210624,EXP,,US-GILEAD-2019-0428527,GILEAD,,69,YR,E,M,Y,86.17,KG,20210623,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bone density decreased;Bone loss;Chronic kidney disease;Decreased appetite;Depression;Economic problem;Emotional distress;Facet joint syndrome;Fibula fracture;Hip arthroplasty;Intervertebral disc protrusion;Multiple fractures;Nephrosclerosis;Osteoarthritis;Osteonecrosis;Pain;Proteinuria;Radiculopathy;Renal failure;Renal tubular injury;Spinal osteoarthritis,168340545,OT,,,168340545,1,20040626,20190710,,,168340545,1,HIV infection
16846100,168461004,4,F,200601,20210407,20190924,20210412,EXP,,US-GILEAD-2019-0429620,GILEAD,,42,YR,A,M,Y,94.79,KG,20210412,,CN,US,US,SUSTIVA,Amnesia;Anhedonia;Ankle fracture;Anxiety;Chronic kidney disease;Decreased activity;Depression;Economic problem;Emotional distress;End stage renal disease;Fatigue;Foot fracture;Loss of personal independence in daily activities;Osteopenia;Osteoporosis;Pain;Quality of life decreased;Rib fracture,168461004,HO,,,168461004,1,200111,2005,,,168461004,1,HIV infection
16847030,168470303,3,F,20150409,20210331,20190924,20210405,EXP,,US-GILEAD-2019-0429491,GILEAD,,64,YR,A,F,Y,49.89,KG,20210405,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Decreased activity;Emotional distress;End stage renal disease;Fatigue;Loss of personal independence in daily activities;Mobility decreased;Osteopenia;Osteoporosis;Pain;Quality of life decreased,168470303,OT,,,168470303,1,20170601,201711,,,168470303,1,HIV infection
16850098,168500984,4,F,2005,20210504,20190925,20210507,EXP,,US-GILEAD-2019-0429508,GILEAD,,41,YR,A,M,Y,77.1,KG,20210507,,LW,US,US,SUSTIVA,Abdominal distension;Anhedonia;Anxiety;Arthritis;Bone density decreased;Bone loss;Bone pain;Carpal tunnel syndrome;Decreased activity;Depression;Economic problem;Emotional distress;Fat tissue increased;Gastrointestinal disorder;Grip strength decreased;Loss of personal independence in daily activities;Nephropathy;Osteopenia;Osteoporosis;Pain;Plantar fasciitis;Quality of life decreased;Tendonitis,168500984,OT,,,168500984,1,2001,2008,,,168500984,1,HIV infection
16851762,168517624,4,F,2015,20210505,20190925,20210510,PER,,US-GILEAD-2019-0429561,GILEAD,,,,A,M,Y,94.33,KG,20210510,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Decreased activity;Depression;Emotional distress;Fear;Gait disturbance;Pain;Quality of life decreased;Renal failure,168517624,OT,,,168517624,1,2005,20140707,,,168517624,1,HIV infection
16853159,168531595,5,F,200408,20210509,20190925,20210517,EXP,,US-GILEAD-2019-0429655,GILEAD,,66,YR,E,M,Y,58.96,KG,20210517,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Blood creatinine increased;Bone density decreased;Economic problem;Emotional distress;Fear;Foot fracture;Loss of personal independence in daily activities;Lower limb fracture;Muscle spasms;Osteopenia;Osteoporosis;Pain;Quality of life decreased;Renal impairment;Rib fracture;Spinal cord compression;Upper limb fracture,168531595,OT,,,168531595,1,20041115,20080926,,,168531595,1,HIV infection
16853616,1685361617,17,F,,20210525,20190926,20210527,EXP,,FR-ABBVIE-19K-056-2935895-00,ABBVIE,,,,N,M,Y,3.23,KG,20210527,,CN,US,FR,EFAVIRENZ.,Foetal exposure during pregnancy;Hydrocele,1685361617,CA,,,1685361617,1,20070510,200705,,,1685361617,1,Maternal exposure timing unspecified
16855068,168550684,4,F,20150902,20210602,20190926,20210603,EXP,,US-GILEAD-2019-0429433,GILEAD,,66,YR,E,M,Y,108.84,KG,20210603,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Decreased activity;Economic problem;Emotional distress;Fatigue;Fear;Osteopenia;Pain;Quality of life decreased;Renal failure,168550684,OT,,,168550684,1,20081218,20170823,,,168550684,1,HIV infection
16855625,168556254,4,F,2010,20210426,20190926,20210429,EXP,,US-GILEAD-2019-0429788,GILEAD,,47,YR,A,M,Y,90.7,KG,20210429,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone disorder;Decreased activity;Depression;Economic problem;Emotional distress;End stage renal disease;Fatigue;Insomnia;Loss of personal independence in daily activities;Pain;Panic attack;Quality of life decreased;Renal failure;Wheelchair user,168556254,OT,,,168556254,1,2006,2010,,,168556254,1,HIV infection
16856671,168566713,3,F,2018,20210517,20190926,20210518,EXP,,US-GILEAD-2019-0429735,GILEAD,,42,YR,A,M,Y,93.88,KG,20210518,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Decreased activity;Economic problem;Emotional distress;End stage renal disease;Fatigue;Loss of personal independence in daily activities;Pain;Quality of life decreased,168566713,HO,,,168566713,1,200411,2009,,,168566713,1,HIV infection
16856872,168568723,3,F,2017,20210622,20190926,20210630,EXP,,US-GILEAD-2019-0429524,GILEAD,,51,YR,A,M,Y,65.3,KG,20210630,,CN,US,US,SUSTIVA,"Anhedonia;Anxiety;Arthralgia;Back pain;Depression;Dysstasia;Economic problem;Emotional distress;Fear-related avoidance of activities;Gait disturbance;Osteoporosis;Pain;Quality of life decreased;Sleep disorder due to general medical condition, insomnia type;Suicidal ideation",168568723,OT,,,168568723,1,20100907,20130514,,,168568723,1,HIV infection
16858174,168581743,3,F,200912,20210604,20190926,20210610,EXP,,US-GILEAD-2019-0429386,GILEAD,,19,YR,A,F,Y,58.96,KG,20210610,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Decreased activity;Economic problem;Emotional distress;End stage renal disease;Loss of personal independence in daily activities;Pain;Quality of life decreased;Renal disorder;Renal failure,168581743,OT,,,168581743,1,2004,20140522,,,168581743,1,HIV infection
16861386,168613863,3,F,2005,20210601,20190927,20210603,EXP,,US-GILEAD-2019-0429649,GILEAD,,45,YR,A,F,Y,,,20210603,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Bone density decreased;Bone pain;Economic problem;Emotional distress;Gait disturbance;Hyperkalaemia;Loss of personal independence in daily activities;Lower limb fracture;Osteoporosis;Pain;Quality of life decreased;Renal failure;Renal pain;Suicidal ideation;Suicide attempt,168613863,OT,,,168613863,1,200408,2017,,,168613863,1,HIV infection
16966245,169662455,5,F,20100224,20210623,20191028,20210630,EXP,,US-GILEAD-2019-0434722,GILEAD,,37,YR,A,F,Y,59.86,KG,20210629,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Arthralgia;Bone density decreased;Chronic kidney disease;Depression;Economic problem;Emotional distress;Haematuria;Nephrolithiasis;Pain;Proteinuria;Pyuria;Red blood cell count increased;Renal failure;Tooth disorder,169662455,OT,,,169662455,1,2001,2006,,,169662455,1,HIV infection
16972969,169729695,5,F,201706,20210622,20191030,20210628,EXP,,US-GILEAD-2019-0434698,GILEAD,,44,YR,A,M,Y,79.37,KG,20210628,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Depression;Economic problem;Emotional distress;Fracture;Osteomalacia;Osteopenia;Pain;Rib fracture;Vitamin D deficiency,169729695,OT,,,169729695,1,200601,200701,,,169729695,1,HIV infection
16973386,169733865,5,F,2005,20210621,20191030,20210624,EXP,,US-GILEAD-2019-0434777,GILEAD,,52,YR,A,F,Y,97.51,KG,20210623,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bone density decreased;Bone loss;Chronic sinusitis;Clavicle fracture;Economic problem;Emotional distress;Femur fracture;Foot fracture;Glomerular filtration rate decreased;Hip arthroplasty;Intervertebral disc disorder;Knee arthroplasty;Multiple fractures;Neuropathy peripheral;Osteoarthritis;Osteonecrosis;Osteopenia;Osteoporosis;Pain;Proteinuria;Renal disorder;Renal failure;Shoulder arthroplasty;Vitamin D deficiency,169733865,OT,,,169733865,1,20021016,20080307,,,169733865,1,HIV infection
16974611,169746115,5,F,2006,20210617,20191030,20210622,EXP,,US-GILEAD-2019-0434773,GILEAD,,56,YR,A,M,Y,,,20210622,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Economic problem;Emotional distress;Facet joint syndrome;Fracture;Intervertebral disc degeneration;Intervertebral disc space narrowing;Lumbar vertebral fracture;Osteopenia;Osteoporosis;Pain;Partner stress;Sacroiliitis;Shoulder operation;Spinal compression fracture;Spinal osteoarthritis;Vertebral foraminal stenosis;Vertebroplasty,169746115,OT,,,169746115,1,2002,2015,,,169746115,1,HIV infection
17075949,170759494,4,F,20081203,20210617,20191126,20210624,EXP,,US-GILEAD-2019-0439508,GILEAD,,49,YR,A,M,Y,86.17,KG,20210624,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Bone density decreased;Cervical vertebral fracture;Economic problem;Emotional distress;Lumbar vertebral fracture;Osteopenia;Osteoporosis;Pain;Rib fracture;Spinal compression fracture;Spinal fusion surgery,170759494,OT,,,170759494,1,20070131,20170502,,,170759494,1,HIV infection
17075959,1707595910,10,F,20160530,20210504,20191126,20210506,EXP,,US-GILEAD-2019-0439481,GILEAD,,59,YR,A,M,Y,64.85,KG,20210506,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Back injury;Chest injury;Chronic kidney disease;Depression;Economic problem;Emotional distress;End stage renal disease;Foot fracture;Joint injury;Limb injury;Osteoarthritis;Osteoporosis;Pain;Pancreatitis;Renal failure;Renal tubular disorder;Renal tubular necrosis;Tooth loss,1707595910,OT,,,1707595910,1,200709,20111028,,,1707595910,1,HIV infection
17149728,171497283,3,F,,20210426,20191213,20210429,EXP,,US-GILEAD-2019-0442009,GILEAD,,,,A,F,Y,52.15,KG,20210429,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Decreased activity;Depression;Economic problem;Emotional distress;End stage renal disease;Pain;Quality of life decreased;Renal failure;Skeletal injury;Tooth injury,171497283,OT,,,171497283,1,2009,2017,,,171497283,1,HIV infection
17156913,171569135,5,F,2015,20210617,20191216,20210627,EXP,,US-GILEAD-2019-0441951,GILEAD,,,,A,M,Y,104.31,KG,20210627,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Drug ineffective;Dysstasia;Economic problem;Emotional distress;Osteoporosis;Pain;Renal disorder;Renal failure,171569135,OT,,,171569135,1,2009,2017,,,171569135,1,HIV infection
17220278,172202785,5,F,2016,20210622,20191231,20210628,EXP,,US-GILEAD-2019-0444912,GILEAD,,39,YR,A,M,Y,108.84,KG,20210628,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;End stage renal disease;Pain;Renal failure,172202785,OT,,,172202785,1,2001,,,,172202785,1,HIV infection
17244332,172443325,5,F,2008,20201203,20200107,20210427,PER,,US-GILEAD-2019-0444850,GILEAD,,,,A,M,Y,86.17,KG,20210427,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Drug resistance;Economic problem;Emotional distress;Pain;Renal failure;Skeletal injury,172443325,OT,,,172443325,1,201302,201604,,,172443325,1,HIV infection
17244347,172443474,4,F,2012,20210514,20200107,20210520,EXP,,US-GILEAD-2019-0444865,GILEAD,,,,A,M,Y,81.63,KG,20210520,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Depression;Economic problem;Emotional distress;Fatigue;Gait disturbance;Pain;Pollakiuria,172443474,OT,,,172443474,1,2003,201510,,,172443474,1,HIV infection
17244469,172444695,5,F,20150612,20210623,20200107,20210629,EXP,,US-GILEAD-2020-0445093,GILEAD,,69,YR,E,M,Y,117.91,KG,20210629,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Mobility decreased;Pain;Proteinuria,172444695,OT,,,172444695,1,200808,20170714,,,172444695,1,HIV infection
17244479,172444794,4,F,201002,20210617,20200107,20210624,EXP,,US-GILEAD-2020-0445100,GILEAD,,43,YR,A,F,Y,,,20210623,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Death;Economic problem;Emotional distress;End stage renal disease;Fracture;Pain;Renal failure,172444794,OT,,,172444794,1,2004,2008,,,172444794,1,HIV infection
17267230,172672304,4,F,20130907,20210622,20200114,20210624,EXP,,US-GILEAD-2020-0445907,GILEAD,,44,YR,A,M,Y,79.37,KG,20210624,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Body height decreased;Bone density decreased;Depression;Economic problem;Emotional distress;Femoral neck fracture;Foot fracture;Mobility decreased;Osteonecrosis;Osteoporosis;Pain;Spinal osteoarthritis,172672304,OT,,,172672304,1,200608,20200108,,,172672304,1,HIV infection
17287878,172878784,4,F,2013,20210617,20200120,20210624,EXP,,US-GILEAD-2020-0447078,GILEAD,,,,A,M,Y,98.9,KG,20210624,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Bone density abnormal;Chronic kidney disease;Depression;Diabetes mellitus inadequate control;Economic problem;Emotional distress;End stage renal disease;Neuropathy peripheral;Pain;Renal failure;Tooth loss,172878784,HO,,,172878784,1,2005,2016,,,172878784,1,HIV infection
17291318,172913185,5,F,2013,20210623,20200121,20210629,EXP,,US-GILEAD-2020-0447102,GILEAD,,,,A,M,Y,104.31,KG,20210629,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Chronic kidney disease;Dental caries;Economic problem;Emotional distress;Pain;Renal impairment;Tooth loss,172913185,OT,,,172913185,1,201111,2013,,,172913185,1,HIV infection
17349167,173491674,4,F,20101014,20210623,20200130,20210628,EXP,,US-GILEAD-2020-0448797,GILEAD,,36,YR,A,M,Y,79.37,KG,20210628,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Depression;Economic problem;Emotional distress;End stage renal disease;Pain;Renal failure,173491674,OT,,,173491674,1,2001,20170802,,,173491674,1,HIV infection
17364204,1736420420,20,F,20070403,20210525,20200204,20210607,EXP,,FR-AUROBINDO-AUR-APL-2020-004851,AUROBINDO,,7,WK,,M,Y,3.23,KG,20210607,,CN,FR,FR,SUSTIVA,Foetal exposure during pregnancy;Hydrocele,1736420420,OT,,,1736420420,1,20070512,20070521,,,1736420420,1,HIV infection
17424136,174241364,4,F,20100506,20210616,20200217,20210621,EXP,,US-GILEAD-2020-0450654,GILEAD,,48,YR,A,M,Y,83.9,KG,20210621,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Bone density decreased;Bone loss;Chronic kidney disease;Economic problem;Emotional distress;Hip arthroplasty;Loss of personal independence in daily activities;Osteopenia;Pain;Renal failure,174241364,OT,,,174241364,1,20070109,200704,,,174241364,1,HIV infection
17435761,174357614,4,F,201509,20210614,20200219,20210616,EXP,,US-GILEAD-2020-0451434,GILEAD,,58,YR,A,M,Y,,,20210616,,CN,US,US,SUSTIVA,Anxiety;Blood creatinine increased;Chronic kidney disease;Depression;Economic problem;Emotional distress;End stage renal disease;Nephrolithiasis;Pain;Renal failure,174357614,OT,,,174357614,1,2010,20190729,,,174357614,1,HIV infection
17510565,175105655,5,F,20190114,20210324,20200306,20210407,EXP,,US-GILEAD-2020-0453649,GILEAD,,44,YR,A,M,Y,75.74,KG,20210407,,LW,US,US,SUSTIVA,Chronic kidney disease;Chronic kidney disease-mineral and bone disorder;Economic problem;Emotional distress;End stage renal disease;Hyperparathyroidism secondary;Pain;Renal failure,175105655,HO,,,175105655,1,20130920,20150501,,,175105655,1,HIV infection
17527872,175278724,4,F,,20210616,20200311,20210621,EXP,,US-GILEAD-2020-0454096,GILEAD,,,,A,M,Y,83.9,KG,20210620,,CN,US,US,SUSTIVA,Bone density decreased;Dysstasia;Economic problem;Emotional distress;Gait disturbance;Osteomalacia;Pain;Renal failure;Vitamin D deficiency,175278724,OT,,,175278724,1,2002,2013,,,175278724,1,HIV infection
17533091,175330916,6,F,200908,20201008,20200312,20210407,EXP,,US-GILEAD-2020-0454085,GILEAD,,47,YR,A,M,Y,101.13,KG,20210407,,LW,US,US,SUSTIVA,Anxiety;Chronic kidney disease;Depression;Economic problem;Emotional distress;End stage renal disease;Nephrotic syndrome;Pain;Renal failure,175330916,OT,,,175330916,1,20090402,201001,,,175330916,1,HIV infection
17536264,175362643,3,F,20110620,20210623,20200313,20210630,EXP,,US-GILEAD-2020-0454512,GILEAD,,43,YR,A,M,Y,77.1,KG,20210630,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Dysstasia;Economic problem;Emotional distress;Gait disturbance;Hip arthroplasty;Osteoarthritis;Osteonecrosis;Pain;Pneumonia;Renal failure,175362643,OT,,,175362643,1,20060629,20150314,,,175362643,1,HIV infection
17539807,175398073,3,F,201210,20210617,20200313,20210618,EXP,,US-GILEAD-2020-0454520,GILEAD,,50,YR,A,M,Y,63.49,KG,20210618,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Cervical spinal stenosis;Emotional distress;Intervertebral disc degeneration;Multiple fractures;Neuropathy peripheral;Osteopenia;Osteoporosis;Pain;Spinal cord compression;Spinal fracture;Upper limb fracture;Wrist fracture,175398073,OT,,,175398073,1,20040217,20040318,,,175398073,1,HIV infection
17575487,175754873,3,F,2015,20210406,20200324,20210412,EXP,,US-GILEAD-2020-0455884,GILEAD,,61,YR,A,M,Y,94.79,KG,20210412,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;Osteopenia;Pain,175754873,OT,,,175754873,1,2006,2018,,,175754873,1,HIV infection
17577715,175777153,3,F,201612,20210511,20200324,20210512,EXP,,US-GILEAD-2020-0456092,GILEAD,,61,YR,A,M,Y,60.77,KG,20210512,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Economic problem;Emotional distress;Osteopenia;Osteoporosis;Pain;Renal impairment;Rib fracture,175777153,OT,,,175777153,1,2006,201709,,,175777153,1,HIV infection
17600360,176003609,9,F,,20210405,20200330,20210408,EXP,,FR-MYLANLABS-2020M1032592,MYLAN,,1,DY,,,Y,,,20210408,,CN,US,FR,EFAVIRENZ.,Cerebral ventricle dilatation;Foetal exposure during pregnancy;Pachygyria;White matter lesion,176003609,CA,,,,,,,,,176003609,1,HIV infection
17678746,176787463,3,F,2003,20210517,20200417,20210520,PER,,US-GILEAD-2020-0459248,GILEAD,,28,YR,A,M,Y,74.83,KG,20210520,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Blood creatinine increased;Bone density decreased;Depression;Disturbance in attention;Economic problem;Emotional distress;Fear;Loss of personal independence in daily activities;Osteopenia;Pain;Renal disorder;Sexual dysfunction;Tooth loss,,,,,176787463,1,200105,20100929,,,176787463,1,HIV infection
17680173,176801734,4,F,20150723,20210617,20200417,20210622,EXP,,US-GILEAD-2020-0459562,GILEAD,,38,YR,A,M,Y,,,20210622,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;End stage renal disease;Pain;Renal failure,176801734,OT,,,176801734,1,20060831,20180106,,,176801734,1,HIV infection
17705396,177053964,4,F,20080115,20210617,20200424,20210624,EXP,,US-GILEAD-2020-0460253,GILEAD,,47,YR,A,M,Y,49.89,KG,20210624,,CN,US,US,SUSTIVA,Bone density decreased;Bone loss;Chronic kidney disease;Economic problem;Emotional distress;Femoral neck fracture;Haematuria;Hip arthroplasty;Osteoarthritis;Osteonecrosis;Osteopenia;Osteoporosis;Pain;Proteinuria;Renal failure;Rib fracture;Tooth loss,177053964,OT,,,177053964,1,2007,20090202,,,177053964,1,HIV infection
17726107,177261073,3,F,201504,20210616,20200429,20210624,EXP,,US-GILEAD-2020-0462425,GILEAD,,56,YR,A,M,Y,77.1,KG,20210623,,CN,US,US,SUSTIVA,Arthralgia;Bone density decreased;Emotional distress;Multiple fractures;Osteopenia;Osteoporosis;Procedural pain;Road traffic accident;Tooth loss;Ulna fracture,177261073,OT,,,177261073,1,201108,201601,,,177261073,1,HIV infection
17734092,177340923,3,F,200812,20210617,20200501,20210624,EXP,,US-GILEAD-2020-0462970,GILEAD,,57,YR,A,M,Y,94.4,KG,20210623,,LW,US,US,SUSTIVA,Bone density decreased;Bone loss;Chronic kidney disease;Emotional distress;Multiple fractures;Osteonecrosis;Pain;Tooth loss,177340923,OT,,,177340923,1,200110,200408,,,177340923,1,HIV infection
17735313,177353133,3,F,20111005,20210617,20200501,20210624,EXP,,US-GILEAD-2020-0462743,GILEAD,,63,YR,A,M,Y,96.15,KG,20210623,,LW,US,US,SUSTIVA,Acute kidney injury;Anxiety;Bone density decreased;Bone loss;Chronic kidney disease;Emotional distress;Loss of personal independence in daily activities;Multiple fractures;Osteonecrosis;Osteopenia;Osteoporosis;Pain;Renal failure;Rib fracture;Vitamin D deficiency,177353133,OT,,,177353133,1,200511,201410,,,177353133,1,HIV infection
17742314,177423143,3,F,,20210323,20200505,20210405,EXP,,CA-ROCHE-2592280,ROCHE,,54,YR,,M,Y,,,20210405,,CN,CA,CA,SUSTIVA,Blood lactic acid increased;Diplopia;Dysphagia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia,177423143,OT,,,,,,,,,177423143,1,HIV infection
17789964,177899645,5,F,20160528,20210623,20200515,20210625,EXP,,US-GILEAD-2020-0467099,GILEAD,,72,YR,E,F,Y,60.77,KG,20210625,,CN,US,US,SUSTIVA,Ankle fracture;Anxiety;Bone density decreased;Depression;Emotional distress;Oedema;Osteoarthritis;Osteopenia;Osteoporosis;Pain;Sciatica;Tooth loss;Wrist fracture,177899645,OT,,,177899645,1,20070409,20160922,,,177899645,1,HIV infection
17869480,178694803,3,F,201106,20210617,20200608,20210622,EXP,,US-GILEAD-2020-0470360,GILEAD,,58,YR,A,M,Y,61.68,KG,20210622,,CN,US,US,SUSTIVA,Blood creatinine increased;Bone density decreased;Chronic kidney disease;Emotional distress;Foot fracture;Glomerular filtration rate decreased;Osteopenia;Pain;Renal failure;Rib fracture,178694803,OT,,,178694803,1,2007,2018,,,178694803,1,HIV infection
17870637,178706375,5,F,2018,20210617,20200608,20210624,EXP,,US-GILEAD-2020-0469433,GILEAD,,50,YR,A,M,Y,74.83,KG,20210624,,CN,US,US,SUSTIVA,Bone density decreased;Emotional distress;Osteoporosis;Pain;Tooth loss,178706375,OT,,,178706375,1,201201,2018,,,178706375,1,HIV infection
17894021,178940213,3,F,200805,20210617,20200615,20210622,EXP,,US-GILEAD-2020-0470809,GILEAD,,48,YR,A,M,Y,85.71,KG,20210622,,LW,US,US,SUSTIVA,Bone density decreased;Bone loss;Emotional distress;Multiple fractures;Osteonecrosis;Osteoporosis;Pain;Tooth loss,178940213,OT,,,178940213,1,200607,201609,,,178940213,1,HIV infection
17910386,179103863,3,F,20110311,20210617,20200618,20210622,EXP,,US-GILEAD-2020-0473224,GILEAD,,47,YR,A,M,Y,53.07,KG,20210622,,LW,US,US,SUSTIVA,Ankle fracture;Chronic kidney disease;Emotional distress;Multiple fractures;Pain;Renal failure;Tibia fracture,179103863,OT,,,179103863,1,2004,201906,,,179103863,1,HIV infection
17917665,179176653,3,F,20120213,20210617,20200619,20210625,EXP,,US-GILEAD-2020-0473759,GILEAD,,60,YR,A,M,Y,76.19,KG,20210625,,LW,US,US,SUSTIVA,Bone density decreased;End stage renal disease;Nephrogenic anaemia;Nephropathy;Osteoporosis;Renal failure,179176653,OT,,,179176653,1,20031206,20040407,,,179176653,1,HIV infection
17919994,179199943,3,F,2005,20210604,20200620,20210608,EXP,,PT-AUROBINDO-AUR-APL-2020-029718,AUROBINDO,,41,YR,,F,Y,,,20210608,,CN,US,PT,EFAVIRENZ.,Drug intolerance;Drug resistance;Fatigue;Hepatic cirrhosis;Hypertension;Nausea;Vomiting,179199943,OT,,,179199943,1,2005,2008,,,179199943,1,Antiretroviral therapy
17930307,179303074,4,F,20100826,20210617,20200623,20210629,EXP,,US-GILEAD-2020-0474953,GILEAD,,49,YR,A,M,Y,97.5,KG,20210629,,LW,US,US,SUSTIVA,Anxiety;Blood creatinine increased;Bone density decreased;Chronic kidney disease;Depression;Emotional distress;Fracture;Osteopenia;Osteoporosis;Pain;Rib fracture;Tooth loss;Upper limb fracture;Weight decreased,179303074,OT,,,179303074,1,2007,20110817,,,179303074,1,HIV infection
17945212,179452123,3,F,2010,20210618,20200626,20210624,EXP,,US-GILEAD-2020-0475190,GILEAD,,,,A,M,Y,79.37,KG,20210623,,CN,US,US,EFAVIRENZ.,Chronic kidney disease;Depression;Renal failure;Renal injury;Renal mass;Skeletal injury;Tooth loss,179452123,OT,,,179452123,1,2001,200506,,,179452123,1,HIV infection
17973430,179734303,3,F,20140603,20210617,20200702,20210624,EXP,,US-GILEAD-2020-0478106,GILEAD,,52,YR,A,F,Y,,,20210623,,LW,US,US,SUSTIVA,Bone density decreased;Chronic kidney disease;Depression;Emotional distress;Fanconi syndrome acquired;Osteoporosis;Pain,179734303,OT,,,179734303,1,2003,2006,,,179734303,1,HIV infection
17977642,179776422,2,F,2005,20210604,20200703,20210608,EXP,,PT-AUROBINDO-AUR-APL-2020-031581,AUROBINDO,,41,YR,,F,Y,,,20210608,,CN,US,PT,EFAVIRENZ.,Drug intolerance;Drug resistance;Fatigue;Hepatic cirrhosis;Hypertension;Nausea;Vomiting,179776422,OT,,,179776422,1,2005,2008,,,179776422,1,Antiretroviral therapy
17981932,179819324,4,F,200708,20210617,20200706,20210624,EXP,,US-GILEAD-2020-0475831,GILEAD,,61,YR,A,F,Y,81.6,KG,20210624,,LW,US,US,SUSTIVA,Acute kidney injury;Bone density decreased;Chronic kidney disease;Emotional distress;End stage renal disease;Osteopenia;Pain;Renal failure,179819324,OT,,,179819324,1,2001,2013,,,179819324,1,HIV infection
17990876,179908767,7,F,,20210411,20200707,20210416,EXP,,GB-MYLANLABS-2020M1060756,MYLAN,,,,,M,Y,,,20210416,,HP,GB,GB,EFAVIRENZ.,Feeling abnormal;Life expectancy shortened;Lung cancer metastatic;Lung neoplasm malignant;Malaise;Metastases to central nervous system,179908767,OT,,,,,,,,,179908767,1,Product used for unknown indication
17994113,179941134,4,F,20130708,20210617,20200708,20210624,EXP,,US-GILEAD-2020-0479635,GILEAD,,48,YR,A,M,Y,111.11,KG,20210624,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthralgia;Bone density decreased;Bone loss;Chronic kidney disease;Emotional distress;Impaired self-care;Intervertebral disc operation;Osteopenia;Osteoporosis;Pain;Tooth loss,179941134,OT,,,179941134,1,20121202,20190109,,,179941134,1,HIV infection
17994819,179948193,3,F,20050607,20210615,20200708,20210621,EXP,,US-GILEAD-2020-0479212,GILEAD,,58,YR,A,M,Y,83.9,KG,20210620,,CN,US,US,SUSTIVA,Anxiety;Bone density decreased;Bone loss;Depression;Dizziness;Emotional distress;Gait disturbance;Lower limb fracture;Osteonecrosis;Pain;Spinal fracture;Tooth loss,179948193,OT,,,179948193,1,200110,201401,,,179948193,1,HIV infection
18002318,180023187,7,F,,20210412,20200709,20210420,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-053886,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210420,,CN,GB,GB,EFAVIRENZ.,Feeling abnormal;Life expectancy shortened;Lung cancer metastatic;Lung neoplasm malignant;Malaise;Metastases to central nervous system,180023187,OT,,,,,,,,,180023187,1,Product used for unknown indication
18007417,180074175,5,F,2012,20210617,20200710,20210624,PER,,US-GILEAD-2020-0481205,GILEAD,,,,A,F,Y,54.42,KG,20210623,,CN,US,US,SUSTIVA,Anxiety;Bone density decreased;Chronic kidney disease;Depression;Drug dependence;Emotional distress;Fanconi syndrome acquired;Femur fracture;Metabolic acidosis;Osteoporosis;Pain;Pancreatitis;Renal failure,180074175,OT,,,180074175,1,20080101,20080601,,,180074175,1,HIV infection
18009569,180095693,3,F,20130505,20210618,20200710,20210622,EXP,,US-GILEAD-2020-0480309,GILEAD,,48,YR,A,M,Y,99.77,KG,20210622,,CN,US,US,SUSTIVA,Agoraphobia;Anxiety;Bone density decreased;Chronic kidney disease;Depression;Emotional distress;Fanconi syndrome acquired;Pain;Renal failure;Skeletal injury,180095693,OT,,,180095693,1,2007,2015,,,180095693,1,HIV infection
18012492,180124924,4,F,20161119,20210617,20200713,20210624,EXP,,US-GILEAD-2020-0477129,GILEAD,,59,YR,A,F,Y,81.63,KG,20210624,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Chronic kidney disease;Emotional distress;End stage renal disease;Multiple fractures;Osteonecrosis;Pain;Renal failure;Tooth loss,180124924,OT,,,180124924,1,2001,20140821,,,180124924,1,HIV infection
18012500,180125002,2,F,,20200703,20200713,20210628,EXP,,CA-TEVA-2020-CA-1798759,TEVA,,,,,M,Y,,,20210628,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction,180125002,OT,,,,,,,,,180125002,1,Product used for unknown indication
18014650,180146502,2,F,,20200703,20200713,20210628,EXP,,CA-TEVA-2020-CA-1798842,TEVA,,,,,M,Y,,,20210628,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,180146502,DE,,,,,,,,,180146502,1,Product used for unknown indication
18015435,180154352,2,F,,20200703,20200713,20210628,EXP,,CA-TEVA-2020-CA-1798836,TEVA,,54,YR,A,M,Y,,,20210628,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,180154352,OT,,,,,,,,,180154352,1,Bipolar disorder
18016136,180161362,2,F,,20200703,20200713,20210628,EXP,,CA-TEVA-2020-CA-1798833,TEVA,,54,YR,A,M,Y,,,20210628,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,180161362,OT,,,,,,,,,180161362,1,Bipolar disorder
18021469,180214695,5,F,20110818,20210617,20200714,20210622,EXP,,US-GILEAD-2020-0481614,GILEAD,,55,YR,A,M,Y,60.32,KG,20210622,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;End stage renal disease;Nephropathy;Pain;Renal failure,180214695,OT,,,180214695,1,2008,2011,,,180214695,1,HIV infection
18022611,1802261110,10,F,,20210419,20200715,20210430,EXP,,GB-AUROBINDO-AUR-APL-2020-034425,AUROBINDO,,,,,M,Y,,,20210430,,CN,GB,GB,EFAVIRENZ.,Feeling abnormal;Hospitalisation;Life expectancy shortened;Lung cancer metastatic;Lung neoplasm malignant;Malaise;Metastases to central nervous system,1802261110,HO,,,,,,,,,1802261110,1,Product used for unknown indication
18023506,180235064,4,F,20121108,20210617,20200715,20210624,EXP,,US-GILEAD-2020-0477191,GILEAD,,39,YR,A,M,Y,76.64,KG,20210623,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Emotional distress;End stage renal disease;Pain;Tooth loss,180235064,OT,,,180235064,1,200801,201401,,,180235064,1,HIV infection
18026883,180268834,4,F,2015,20210618,20200715,20210624,EXP,,US-GILEAD-2020-0479893,GILEAD,,,,E,F,Y,,,20210624,,LW,US,US,SUSTIVA,Bone density decreased;Chronic kidney disease;Emotional distress;End stage renal disease;Pain;Renal failure;Tooth loss,180268834,OT,,,180268834,1,2011,2015,,,180268834,1,HIV infection
18033841,180338415,5,F,20150224,20210617,20200716,20210624,PER,,US-GILEAD-2020-0483577,GILEAD,,47,YR,A,M,Y,68.03,KG,20210623,,LW,US,US,SUSTIVA,Acute kidney injury;Bone loss;Chronic kidney disease;Drug ineffective;Emotional distress;End stage renal disease;Pain;Renal failure;Tooth extraction;Tooth fracture,180338415,OT,,,180338415,1,2006,2015,,,180338415,1,HIV infection
18038721,180387212,2,F,,20210519,20200717,20210531,EXP,,SG-LUPIN PHARMACEUTICALS INC.-2020-03425,LUPIN,,,,A,M,Y,,,20210601,,HP,SG,SG,EFAVIRENZ.,Retroviral rebound syndrome,180387212,OT,,,,,,,,,180387212,1,HIV infection
18038722,180387223,3,F,,20210519,20200717,20210603,EXP,,SG-LUPIN PHARMACEUTICALS INC.-2020-03426,LUPIN,,,,A,M,Y,,,20210603,,HP,SG,SG,EFAVIRENZ.,Drug resistance;Retroviral rebound syndrome,180387223,OT,,,,,,,,,180387223,1,HIV infection
18040288,180402882,2,F,20140609,20210505,20200717,20210507,EXP,,US-GILEAD-2020-0483314,GILEAD,,38,YR,A,M,Y,,,20210507,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Chronic kidney disease;Decreased activity;Emotional distress;Fear;Insomnia;Loss of personal independence in daily activities;Pain;Quality of life decreased,180402882,OT,,,180402882,1,200604,20181126,,,180402882,1,HIV infection
18040753,180407534,4,F,200912,20210616,20200717,20210622,EXP,,US-GILEAD-2020-0481716,GILEAD,,73,YR,E,M,Y,68.93,KG,20210622,,CN,US,US,SUSTIVA,Acute kidney injury;Bone density decreased;Chronic kidney disease;Emotional distress;End stage renal disease;Osteoporosis;Pain;Renal failure;Renal tubular necrosis;Tooth loss,180407534,OT,,,180407534,1,200606,2009,,,180407534,1,HIV infection
18045782,180457822,2,F,,20200713,20200720,20210628,EXP,,CA-TEVA-2020-CA-1801616,TEVA,,52,YR,A,M,Y,,,20210628,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,180457822,CA,,,,,,,,,180457822,1,HIV infection
18055939,1805593910,10,F,201308,20210518,20200722,20210526,PER,,US-GILEAD-2020-0484456,GILEAD,,58,YR,A,M,Y,84.81,KG,20210526,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Back pain;Bone density decreased;Depression;Drug ineffective;Emotional distress;Fatigue;Genotype drug resistance test positive;Mood altered;Osteoporosis;Pain;Rash pruritic;Rib fracture;Sinus headache,1805593910,OT,,,1805593910,1,2001,2010,,,1805593910,1,HIV infection
18096248,180962483,3,F,2015,20210615,20200730,20210618,PER,,US-GILEAD-2020-0487166,GILEAD,,56,YR,A,M,Y,,,20210618,,CN,US,US,SUSTIVA,Acute kidney injury;Fanconi syndrome acquired;Proteinuria;Renal impairment,180962483,HO,,,180962483,1,20070227,20170919,,,180962483,1,HIV infection
18100590,181005905,5,F,,20210513,20200801,20210521,EXP,,FR-AUROBINDO-AUR-APL-2020-037112,AUROBINDO,,,,I,,Y,,,20210521,,MD,FR,FR,EFAVIRENZ.,Foetal exposure during pregnancy;Pachygyria,181005905,CA,,,,,,,,,181005905,1,Product used for unknown indication
18112870,181128703,3,F,20130912,20210617,20200805,20210624,EXP,,US-GILEAD-2020-0486808,GILEAD,,75,YR,E,F,Y,118,KG,20210624,,LW,US,US,SUSTIVA,Acute kidney injury;Ankle fracture;Anxiety;Blood creatinine increased;Bone density decreased;Chronic kidney disease;Depression;Emotional distress;End stage renal disease;Foot fracture;Multiple fractures;Osteopenia;Osteoporosis;Pain;Radius fracture;Tooth loss;Wrist fracture,181128703,OT,,,181128703,1,20111130,20120824,,,181128703,1,HIV infection
18114349,181143494,4,F,2012,20210617,20200805,20210624,EXP,,US-GILEAD-2020-0488911,GILEAD,,,,A,M,Y,83.45,KG,20210624,,LW,US,US,SUSTIVA,Bone density decreased;Bone loss;Chronic kidney disease;Emotional distress;Osteoarthritis;Osteonecrosis;Pain;Polyneuropathy;Renal cyst;Renal failure;Tooth loss;Vitamin D deficiency,181143494,OT,,,181143494,1,20000101,201803,,,181143494,1,Acquired immunodeficiency syndrome
18117927,181179274,4,F,20171018,20210623,20200806,20210628,EXP,,US-GILEAD-2020-0488914,GILEAD,,52,YR,A,M,Y,74.83,KG,20210628,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone disorder;Depression;Dysstasia;Emotional distress;Gait disturbance;Mobility decreased;Nephropathy;Osteonecrosis;Pain;Renal injury;Skeletal injury;Tooth disorder;Tooth loss,181179274,OT,,,181179274,1,2001,2003,,,181179274,1,HIV infection
18119698,181196983,3,F,201701,20210617,20200806,20210625,EXP,,US-GILEAD-2020-0487217,GILEAD,,56,YR,A,M,Y,180,KG,20210625,,LW,US,US,SUSTIVA,Anxiety;Asthenia;Bone density decreased;Bone loss;Chronic kidney disease;Creatinine urine increased;Emotional distress;Fatigue;Osteonecrosis;Osteopenia;Pain;Renal failure;Tooth disorder;Tooth loss,181196983,OT,,,181196983,1,20050107,201512,,,181196983,1,HIV infection
18120238,181202382,2,F,201504,20210615,20200806,20210618,EXP,,US-GILEAD-2020-0484417,GILEAD,,74,YR,E,M,Y,90.7,KG,20210618,,CN,US,US,SUSTIVA,Chronic kidney disease;Emotional distress;Gait disturbance;Nephropathy;Pain;Renal impairment,181202382,OT,,,181202382,1,2004,2013,,,181202382,1,HIV infection
18129721,181297214,4,F,2016,20210510,20200810,20210514,EXP,,US-GILEAD-2020-0488477,GILEAD,,44,YR,A,M,Y,122.45,KG,20210514,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bronchitis;Chronic kidney disease;Depression;Emotional distress;Hepatic function abnormal;Pain;Renal impairment;Spinal fracture;Wrist fracture,181297214,OT,,,181297214,1,2001,2016,,,181297214,1,HIV infection
18148773,181487734,4,F,20140729,20210505,20200813,20210507,EXP,,US-GILEAD-2020-0489270,GILEAD,,60,YR,A,M,Y,88.44,KG,20210507,,LW,US,US,EFAVIRENZ.;SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Emotional distress;Osteonecrosis;Osteopenia;Osteoporosis;Pain;Spinal compression fracture,181487734,OT,,,181487734,1,2009,20160914,,,181487734,1,HIV infection
18152088,181520884,4,F,2017,20210527,20200814,20210601,PER,,US-GILEAD-2020-0489879,GILEAD,,,,A,M,Y,81.63,KG,20210601,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Emotional distress;Osteopenia;Pain,,,,,181520884,1,2008,201710,,,181520884,1,HIV infection
18157575,181575753,3,F,2018,20210510,20200817,20210511,EXP,,US-GILEAD-2020-0490404,GILEAD,,,,A,F,Y,113.38,KG,20210511,,LW,US,US,SUSTIVA,Anxiety;Bone density decreased;Depression;Emotional distress;Osteoporosis;Pain,181575753,OT,,,181575753,1,2008,2016,,,181575753,1,HIV infection
18158198,181581983,3,F,2012,20210505,20200817,20210510,EXP,,US-GILEAD-2020-0489363,GILEAD,,55,YR,A,F,Y,75.28,KG,20210510,,LW,US,US,SUSTIVA,Acute kidney injury;Bone density decreased;Chronic kidney disease;Emotional distress;Femur fracture;Gait disturbance;Hip fracture;Lower limb fracture;Mental impairment;Osteoporosis;Pain,181581983,OT,,,181581983,1,2003,20131115,,,181581983,1,HIV infection
18158546,181585463,3,F,201403,20210426,20200817,20210428,EXP,,US-GILEAD-2020-0489318,GILEAD,,40,YR,A,M,Y,74.83,KG,20210428,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Emotional distress;Pain;Renal failure,181585463,OT,,,181585463,1,2010,2013,,,181585463,1,HIV infection
18164264,181642643,3,F,20171211,20210507,20200818,20210511,EXP,,US-GILEAD-2020-0490119,GILEAD,,64,YR,,M,Y,87.98,KG,20210511,,LW,US,US,EFAVIRENZ.;SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Bone density decreased;Emotional distress;Osteopenia;Pain,181642643,OT,,,181642643,1,2008,201808,,,181642643,1,Product used for unknown indication
18168943,181689435,5,F,2009,20210509,20200818,20210517,EXP,,US-GILEAD-2020-0489652,GILEAD,,,,A,M,Y,58.96,KG,20210517,,CN,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Blood creatinine increased;Bone density decreased;Bone disorder;Emotional distress;Hip fracture;Osteoporosis;Pain;Protein urine present;Renal impairment;Rotator cuff syndrome;Tendon rupture;Wrist fracture,181689435,OT,,,181689435,1,2006,201612,,,181689435,1,HIV infection
18172978,181729784,4,F,2005,20210409,20200819,20210414,EXP,,US-GILEAD-2020-0490072,GILEAD,,56,YR,A,M,Y,78.46,KG,20210414,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Depression;Emotional distress;Nightmare;Pain,181729784,OT,,,181729784,1,200211,201706,,,181729784,1,HIV infection
18173335,181733353,3,F,20110712,20200918,20200819,20210408,EXP,,US-GILEAD-2020-0489972,GILEAD,,63,YR,A,M,Y,62.59,KG,20210408,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Bone density decreased;Emotional distress;Femur fracture;Hip fracture;Osteoporosis,181733353,OT,,,181733353,1,2002,20160908,,,181733353,1,HIV infection
18193790,181937904,4,F,,20210607,20200825,20210610,EXP,,CA-ASTRAZENECA-2020SF06056,ASTRAZENECA,,54,YR,,M,Y,,,20210610,,CN,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,181937904,DE,,,,,,,,,181937904,1,Bipolar disorder
18194619,181946194,4,F,,20210621,20200825,20210622,EXP,,CA-ASTRAZENECA-2020SF06767,ASTRAZENECA,,54,YR,,M,Y,,,20210622,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,181946194,OT,,,,,,,,,181946194,1,Bipolar disorder
18194796,181947962,2,F,,20210521,20200825,20210528,EXP,,CA-ASTRAZENECA-2020SF06288,ASTRAZENECA,,,,,M,Y,,,20210528,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction,181947962,OT,,,,,,,,,181947962,1,Product used for unknown indication
18195354,181953544,4,F,2008,20210507,20200825,20210510,EXP,,US-GILEAD-2020-0490990,GILEAD,,,,A,F,Y,53.06,KG,20210510,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Depression;Emotional distress;Fanconi syndrome acquired;Foot fracture;Hip fracture;Multiple fractures;Osteoporosis;Pain,181953544,HO,,,181953544,1,2006,2016,,,181953544,1,HIV infection
18198021,181980212,2,F,2015,20210405,20200826,20210408,EXP,,US-GILEAD-2020-0491862,GILEAD,,44,YR,A,M,Y,81.63,KG,20210408,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Dysstasia;Emotional distress;Loose tooth;Multiple fractures;Osteopenia;Osteoporosis;Pain;Stress fracture,181980212,OT,,,181980212,1,2004,201801,,,181980212,1,HIV infection
18205129,182051294,4,F,2014,20210420,20200828,20210422,PER,,US-GILEAD-2020-0491856,GILEAD,,,,A,M,Y,87.53,KG,20210422,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Eating disorder;Emotional distress;Pain;Renal failure;Urinary incontinence,182051294,OT,,,182051294,1,2010,2012,,,182051294,1,HIV infection
18222401,182224012,2,F,,20210607,20200902,20210615,EXP,,CA-ASTRAZENECA-2020SF09264,ASTRAZENECA,,54,YR,,M,Y,,,20210615,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,182224012,OT,,,,,,,,,182224012,1,Bipolar disorder
18224609,182246095,5,F,2006,20210617,20200902,20210628,EXP,,US-GILEAD-2020-0492507,GILEAD,,56,YR,A,M,Y,77.1,KG,20210628,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthralgia;Asthenia;Back pain;Chronic kidney disease;Depression;Emotional distress;End stage renal disease;Gait disturbance;Hyperkalaemia;Osteonecrosis;Pain;Renal failure;Tooth loss,182246095,OT,,,182246095,1,20051007,20060913,,,182246095,1,HIV infection
18232482,182324822,2,F,,20210607,20200904,20210615,EXP,,CA-ASTRAZENECA-2020SF09822,ASTRAZENECA,,,,,M,Y,,,20210615,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction,182324822,HO,,,,,,,,,182324822,1,Product used for unknown indication
18245660,182456602,2,F,2015,20210402,20200909,20210406,EXP,,US-GILEAD-2020-0494046,GILEAD,,,,A,M,Y,106.6,KG,20210406,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Pain,182456602,OT,,,182456602,1,2004,201205,,,182456602,1,HIV infection
18251324,182513243,3,F,20110520,20210331,20200910,20210408,PER,,US-GILEAD-2020-0494275,GILEAD,,50,YR,A,F,Y,111.11,KG,20210408,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arteriovenous fistula thrombosis;Bone density decreased;Emotional distress;End stage renal disease;Gait inability;Multiple fractures;Pain;Renal failure,182513243,OT,,,182513243,1,2006,20080225,,,182513243,1,HIV infection
18252769,182527693,3,F,2016,20210301,20200910,20210517,EXP,,US-GILEAD-2020-0494492,GILEAD,,67,YR,E,M,Y,63.49,KG,20210517,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Dysstasia;Emotional distress;Femur fracture;Gait disturbance;Multiple fractures;Osteoporosis;Pain;Pelvic fracture;Upper limb fracture;Wrist fracture,182527693,OT,,,182527693,1,2010,201612,,,182527693,1,HIV infection
18279239,182792394,4,F,2013,20210414,20200917,20210416,EXP,,US-GILEAD-2020-0494039,GILEAD,,,,A,M,Y,83.9,KG,20210416,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Hypertension;Pain;Renal failure,182792394,OT,,,182792394,1,2013,2019,,,182792394,1,HIV infection
18296443,182964435,5,F,20070808,20210623,20200922,20210625,EXP,,US-GILEAD-2020-0495296,GILEAD,,51,YR,A,M,Y,63.49,KG,20210625,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bone density decreased;Chronic kidney disease;Depression;Diarrhoea;Emotional distress;End stage renal disease;Haematuria;Hyperlipidaemia;Hypertension;Hypophosphataemia;Intervertebral disc degeneration;Nephrolithiasis;Osteopenia;Osteoporosis;Pain;Proteinuria;Renal cyst;Renal failure;Renal injury;Skeletal injury;Spinal osteoarthritis;Vertebral foraminal stenosis;Vitamin D deficiency,182964435,OT,,,182964435,1,2001,20080508,,,182964435,1,HIV infection
18388864,183888643,3,F,201412,20210617,20201015,20210625,EXP,,US-GILEAD-2020-0498938,GILEAD,,49,YR,A,F,Y,58.97,KG,20210625,,LW,US,US,SUSTIVA,Asthenia;Emotional distress;End stage renal disease;Nausea;Pain;Renal failure,183888643,OT,,,183888643,1,201611,202001,,,183888643,1,HIV infection
18401629,184016294,4,F,201905,20210623,20201019,20210628,EXP,,US-GILEAD-2020-0499532,GILEAD,,57,YR,A,M,Y,93.88,KG,20210628,,LW,US,US,SUSTIVA,Bone density decreased;Bone loss;Mobility decreased;Osteonecrosis;Renal injury;Skeletal injury;Tooth injury,184016294,HO,,,184016294,2,20040101,20060801,,,184016294,1,HIV infection
18420531,184205314,4,F,2007,20210509,20201023,20210517,EXP,,US-GILEAD-2020-0499315,GILEAD,,64,YR,A,M,Y,113.38,KG,20210517,,LW,US,US,SUSTIVA,Acute kidney injury;Back pain;Bone density decreased;Chronic kidney disease;Condition aggravated;Decreased activity;Depression;Emotional distress;Obesity;Pain;Post-traumatic stress disorder;Renal failure;Renal impairment;Sleep apnoea syndrome;Weight increased,184205314,OT,,,184205314,1,2003,201205,,,184205314,1,HIV infection
18430490,184304903,3,F,2012,20210617,20201027,20210624,EXP,,US-GILEAD-2020-0501280,GILEAD,,,,A,M,Y,80.73,KG,20210622,,CN,US,US,SUSTIVA,Anxiety;Bone loss;Depression;Osteonecrosis,184304903,OT,,,184304903,1,200408,201904,,,184304903,1,HIV infection
18487650,184876505,5,F,20201027,20210414,20201111,20210416,EXP,,CN-GILEAD-2020-0503255,GILEAD,,,,A,M,Y,80,KG,20210416,,HP,CN,CN,TENOFOVIR DISOPROXIL FUMARATE/LAMIVUDINE/EFAVIRENZ,Drug eruption;Pneumonia,184876505,HO,,,184876505,1,20201014,20201027,,,184876505,1,HIV infection
18553691,185536913,3,F,20130725,20210617,20201127,20210622,EXP,,US-GILEAD-2020-0505720,GILEAD,,54,YR,A,F,Y,,,20210622,,CN,US,US,SUSTIVA,Anaemia;Blood creatinine increased;Bone density decreased;Chronic kidney disease;Chronic kidney disease-mineral and bone disorder;End stage renal disease;Glomerular filtration rate increased;Muscular weakness;Protein total abnormal;Protein total increased;Renal failure;Tooth loss,185536913,OT,,,185536913,1,20090701,20111106,,,185536913,1,HIV infection
18632989,186329893,3,F,201411,20210407,20201218,20210414,PER,,US-GILEAD-2020-0509294,GILEAD,,61,YR,A,M,Y,41.73,KG,20210414,,LW,US,US,SUSTIVA,Chronic kidney disease;Emotional distress;Enuresis;Feeling hot;Feeling jittery;Glomerular filtration rate abnormal;Nightmare;Pain;Renal impairment,186329893,OT,,,186329893,1,2010,201307,,,186329893,1,HIV infection
18641058,186410582,2,F,201309,20210430,20201221,20210503,EXP,,US-GILEAD-2020-0509278,GILEAD,,49,YR,A,F,Y,147.39,KG,20210503,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Cardiac failure congestive;Depression;Emotional distress;End stage renal disease;Fatigue;Lethargy;Negative thoughts;Pain;Renal failure;Renal impairment,186410582,OT,,,186410582,1,2001,201812,,,186410582,1,HIV infection
18646310,186463102,2,F,2011,20210608,20201222,20210614,PER,,US-GILEAD-2020-0509313,GILEAD,,,,A,M,Y,77.1,KG,20210614,,LW,US,US,EFAVIRENZ.,Anhedonia;Anxiety;Emotional distress;Gait disturbance;Hypertension;Pain;Renal failure;Renal impairment;Sleep disorder,186463102,OT,,,186463102,1,2004,2015,,,186463102,1,HIV infection
18649235,186492352,2,F,2009,20210608,20201222,20210614,EXP,,US-GILEAD-2020-0509311,GILEAD,,54,YR,A,M,Y,81,KG,20210614,,LW,US,US,SUSTIVA,Acute kidney injury;Anaemia;Anhedonia;Anxiety;Chronic kidney disease;Depression;Emotional distress;Fatigue;Hyperkalaemia;Hyperparathyroidism secondary;Hypertension;Oxygen saturation abnormal;Pain;Renal impairment;Vitamin D deficiency;Weight increased,186492352,OT,,,186492352,1,2009,20140520,,,186492352,1,HIV infection
18654345,186543453,3,F,20200731,20210413,20201223,20210415,EXP,,ZA-GILEAD-2020-0494586,GILEAD,,40,YR,A,F,Y,70.7,KG,20210415,,MD,ZA,ZA,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion spontaneous;Maternal exposure during pregnancy;Transaminases increased,186543453,OT,,,186543453,1,20170309,20200910,,,186543453,1,HIV infection
18654621,186546212,2,F,2010,20210407,20201223,20210414,EXP,,US-GILEAD-2020-0509300,GILEAD,,,,A,M,Y,68.04,KG,20210414,,LW,US,US,EFAVIRENZ.;SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Depression;Emotional distress;Hypertension;Pain;Tooth loss,186546212,OT,,,186546212,1,2004,2006,,,186546212,1,HIV infection
18658223,186582232,2,F,2010,20210525,20201224,20210527,EXP,,US-GILEAD-2020-0509266,GILEAD,,,,A,M,Y,77.1,KG,20210527,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Emotional distress;Multiple fractures;Osteoporosis;Pain;Wrist fracture,186582232,OT,,,186582232,1,2001,2010,,,186582232,1,HIV infection
18658805,186588053,3,F,20160415,20210623,20201224,20210630,EXP,,US-GILEAD-2020-0509256,GILEAD,,,,,M,Y,72.56,KG,20210629,,CN,US,US,SUSTIVA,Bone loss;Emotional distress;Osteonecrosis;Pain,186588053,OT,,,186588053,1,20101201,20130831,,,186588053,1,HIV infection
18661112,186611122,2,F,2017,20210526,20201224,20210531,PER,,US-GILEAD-2020-0509320,GILEAD,,,,A,F,Y,109.77,KG,20210530,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Emotional distress;Pain;Renal failure,186611122,HO,,,186611122,1,2001,2006,,,186611122,1,HIV infection
18661131,186611312,2,F,2014,20210430,20201224,20210505,EXP,,US-GILEAD-2020-0509306,GILEAD,,65,YR,E,M,Y,,,20210505,,LW,US,US,EFAVIRENZ.,Acute kidney injury;Anhedonia;Anxiety;Diarrhoea;Discomfort;Emotional distress;End stage renal disease;Nausea;Pain;Renal failure;Renal impairment,186611312,DE,,,186611312,1,2010,20150320,,,186611312,1,HIV infection
18686617,186866173,3,F,2012,20210505,20201230,20210512,EXP,,AU-ABBVIE-20K-008-3710226-00,ABBVIE,,,,,F,Y,,,20210512,,HP,AU,AU,EFAVIRENZ.,Behaviour disorder;Central nervous system inflammation;Cerebellar syndrome;Chorea;Confusional state;Disorientation;Dysarthria;Dysdiadochokinesis;Gait disturbance;HIV-associated neurocognitive disorder;Hypophagia;Loss of personal independence in daily activities;Magnetic resonance imaging head abnormal;Meningitis viral;Meningoencephalitis viral;Parainfluenzae virus infection;Pathogen resistance;Rhinitis;Treatment noncompliance;Viral mutation identified,186866173,HO,,,186866173,2,2012,,,,186866173,1,Product used for unknown indication
18696971,186969713,3,F,20130823,20210617,20210104,20210622,EXP,,US-GILEAD-2020-0510869,GILEAD,,60,YR,A,M,Y,74.83,KG,20210622,,CN,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Chronic obstructive pulmonary disease;Depression;Dyspnoea;Emotional distress;End stage renal disease;Fatigue;Impaired work ability;Pain;Walking disability,186969713,HO,,,186969713,1,2004,2010,,,186969713,1,HIV infection
18705278,187052783,3,F,20090326,20210509,20210106,20210517,EXP,,US-GILEAD-2021-0511357,GILEAD,,34,YR,A,M,Y,78.93,KG,20210517,,LW,US,US,SUSTIVA,"Acute kidney injury;Anxiety;Chronic kidney disease;Clavicle fracture;Delusional disorder, unspecified type;Depression;End stage renal disease;Night sweats;Renal failure;Tooth loss",187052783,OT,,,187052783,1,2004,2013,,,187052783,1,HIV infection
18733265,187332653,3,F,200908,20210617,20210113,20210622,EXP,,US-GILEAD-2021-0512540,GILEAD,,51,YR,A,F,Y,93.42,KG,20210622,,CN,US,US,SUSTIVA,Anxiety;Chronic kidney disease;Depression;End stage renal disease,187332653,OT,,,187332653,1,2017,2019,,,187332653,1,HIV infection
18755838,187558382,2,F,2004,20210112,20210119,20210611,EXP,,PT-VIIV HEALTHCARE LIMITED-PT2021010113,VIIV,,21,YR,,M,Y,,,20210611,,MD,PT,PT,EFAVIRENZ.,Alcoholism;Drug resistance;Myocardial infarction;Pancreatitis acute;Pathogen resistance;Treatment noncompliance,187558382,OT,,,187558382,1,2007,2010,,,187558382,1,Product used for unknown indication
18755857,187558572,2,F,2004,20210112,20210119,20210611,EXP,,PT-GLAXOSMITHKLINE-PT2021010113,GLAXOSMITHKLINE,,21,YR,,M,Y,,,20210611,,MD,PT,PT,EFAVIRENZ.,Alcoholism;Drug resistance;Myocardial infarction;Pancreatitis acute;Pathogen resistance;Treatment noncompliance,187558572,OT,,,187558572,1,2007,2010,,,187558572,1,Product used for unknown indication
18770483,187704832,2,F,200508,20210426,20210122,20210428,EXP,,US-GILEAD-2021-0512294,GILEAD,,46,YR,A,M,Y,81.63,KG,20210428,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Emotional distress;Osteoporosis;Pain,187704832,OT,,,187704832,1,200507,200508,,,187704832,1,HIV infection
18782541,187825412,2,F,,20210609,20210125,20210616,EXP,,CA-009507513-2101CAN009446,MERCK,,,,,M,Y,,,20210616,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction,187825412,HO,,,,,,,,,187825412,1,Product used for unknown indication
18786658,187866582,2,F,2013,20210514,20210126,20210520,EXP,,US-GILEAD-2021-0513366,GILEAD,,,,A,M,Y,54.42,KG,20210520,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Osteoporosis;Pain;Upper limb fracture,187866582,OT,,,187866582,1,2006,201404,,,187866582,1,HIV infection
18796595,187965952,2,F,2005,20210513,20210128,20210518,EXP,,US-GILEAD-2021-0513358,GILEAD,,64,YR,A,M,Y,,,20210518,,CN,US,US,EFAVIRENZ.,Anhedonia;Anxiety;Clavicle fracture;Depression;Emotional distress;Osteonecrosis;Osteopenia;Osteoporosis;Pain;Upper limb fracture;Wrist fracture,187965952,OT,,,187965952,1,2005,2015,,,187965952,1,HIV infection
18796763,187967632,2,F,2007,20210423,20210128,20210427,EXP,,US-GILEAD-2021-0513451,GILEAD,,,,A,M,Y,70.3,KG,20210427,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Emotional distress;Osteoporosis;Pain;Renal injury,187967632,OT,,,187967632,1,2005,2010,,,187967632,1,HIV infection
18796772,187967722,2,F,,20210520,20210128,20210521,PER,,US-GILEAD-2021-0513381,GILEAD,,,,A,M,Y,79.37,KG,20210521,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Depression;Emotional distress;Osteopenia;Pain;Wrist fracture,,,,,187967722,1,2011,2019,,,187967722,1,HIV infection
18799271,187992713,3,F,2010,20210525,20210128,20210528,EXP,,US-GILEAD-2021-0513354,GILEAD,,,,A,M,Y,119.73,KG,20210528,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Depression;Emotional distress;Foot fracture;Jaw fracture;Nephropathy;Osteonecrosis;Osteopenia;Osteoporosis;Pain,187992713,OT,,,187992713,1,2005,2012,,,187992713,1,HIV infection
18801757,188017572,2,F,2009,20210430,20210128,20210504,EXP,,US-GILEAD-2021-0513415,GILEAD,,,,,F,Y,58.96,KG,20210504,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Hypertension;Lower limb fracture;Osteoporosis;Pain,188017572,OT,,,188017572,1,2006,2004,,,188017572,1,HIV infection
18806899,188068993,3,F,2007,20210614,20210129,20210622,EXP,,US-GILEAD-2021-0513418,GILEAD,,,,A,M,Y,77.1,KG,20210622,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Emotional distress;Lower limb fracture;Osteopenia;Osteoporosis;Pain;Tibia fracture,188068993,OT,,,188068993,1,2003,2004,,,188068993,1,HIV infection
18855729,188557293,3,F,,20210511,20210205,20210513,EXP,,AU-GILEAD-2021-0516233,GILEAD,,52,YR,A,F,Y,,,20210513,,HP,AU,AU,EFAVIRENZ.,Behaviour disorder;Central nervous system inflammation;Cerebellar syndrome;Chorea;Confusional state;Disorientation;Dysarthria;Dysdiadochokinesis;Gait disturbance;HIV-associated neurocognitive disorder;Hypophagia;Loss of personal independence in daily activities;Magnetic resonance imaging head abnormal;Meningitis viral;Meningoencephalitis viral;Parainfluenzae virus infection;Past-pointing;Pathogen resistance;Rhinitis;Treatment noncompliance;Viraemia;Viral mutation identified,188557293,OT,,,,,,,,,188557293,1,HIV infection
18869891,188698912,2,F,2015,20210614,20210209,20210617,EXP,,US-GILEAD-2021-0515572,GILEAD,,,,A,F,Y,73.92,KG,20210616,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Pain,188698912,OT,,,188698912,1,2011,2011,,,188698912,1,Product used for unknown indication
18871837,188718372,2,F,2015,20210528,20210210,20210531,EXP,,US-GILEAD-2021-0515563,GILEAD,,,,A,M,Y,79.82,KG,20210531,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Depression;Emotional distress;Osteoporosis;Pain;Proteinuria;Renal failure;Renal injury,188718372,OT,,,188718372,1,2004,2006,,,188718372,1,HIV infection
18871840,188718402,2,F,2008,20210601,20210210,20210603,EXP,,US-GILEAD-2021-0515565,GILEAD,,,,A,F,Y,45.36,KG,20210603,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Hypertension;Pain,188718402,OT,,,188718402,1,2008,2014,,,188718402,1,HIV infection
18874084,188740842,2,F,2009,20210607,20210210,20210611,PER,,US-GILEAD-2021-0515558,GILEAD,,,,A,F,Y,66.67,KG,20210611,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Emotional distress;Osteopenia;Pain;Renal impairment,188740842,OT,,,188740842,1,2004,2017,,,188740842,1,HIV infection
18874963,188749632,2,F,2007,20210603,20210211,20210607,EXP,,US-GILEAD-2021-0515547,GILEAD,,,,E,F,Y,68.03,KG,20210607,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Depression;Emotional distress;Osteoporosis;Pain;Renal impairment,188749632,HO,,,188749632,1,2004,2006,,,188749632,1,HIV infection
18881838,188818382,2,F,2016,20210610,20210212,20210611,EXP,,US-GILEAD-2021-0515536,GILEAD,,,,A,M,Y,175,KG,20210611,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Emotional distress;Osteoarthritis;Osteoporosis;Pain,188818382,OT,,,188818382,2,201106,2017,,,188818382,1,HIV infection
18883984,188839843,3,F,20151013,20210611,20210211,20210615,PER,,US-GILEAD-2021-0515564,GILEAD,,53,YR,A,F,Y,72.12,KG,20210615,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Emotional distress;Osteopenia;Pain;Renal impairment,188839843,OT,,,188839843,1,200701,201109,,,188839843,1,HIV infection
18888480,188884802,2,F,,20210621,20210212,20210623,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013018,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210623,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,188884802,OT,,,,,,,,,188884802,1,Product used for unknown indication
18898598,188985982,2,F,20170509,20210621,20210216,20210625,EXP,,US-GILEAD-2021-0515747,GILEAD,,56,YR,A,M,Y,89.8,KG,20210625,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Emotional distress;Musculoskeletal disorder;Osteoporosis;Pain,188985982,OT,,,188985982,1,2001,201708,,,188985982,1,HIV infection
18923115,189231153,3,F,,20210607,20210222,20210616,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013419,BRISTOL MYERS SQUIBB,,52,YR,,M,Y,,,20210616,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Blood lactic acid increased;Diplopia;Dysphagia;Extraocular muscle paresis;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia,189231153,OT,,,,,,,,,189231153,1,HIV infection
18923549,189235493,3,F,,20210621,20210222,20210628,EXP,,CA-BAUSCH-BL-2021-006053,BAUSCH AND LOMB,,,,,M,Y,,,20210628,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189235493,HO,,,,,,,,,189235493,1,Product used for unknown indication
18925910,189259102,2,F,,20210616,20210222,20210625,EXP,,CA-AUROBINDO-AUR-APL-2021-006678,AUROBINDO,,54,YR,,M,Y,,,20210625,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,189259102,DE,,,,,,,,,189259102,1,HIV infection
18928033,189280334,4,F,,20210621,20210223,20210629,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK050110,VIIV,,,,,M,Y,,,20210629,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189280334,HO,,,,,,,,,189280334,1,Product used for unknown indication
18928106,189281064,4,F,,20210621,20210223,20210629,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK050110,GLAXOSMITHKLINE,,,,,M,Y,,,20210629,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189281064,HO,,,,,,,,,189281064,1,Product used for unknown indication
18932084,189320842,2,F,,20210614,20210224,20210623,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-084598",BOEHRINGER INGELHEIM,,52,YR,A,M,Y,,,20210623,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,189320842,OT,,,,,,,,,189320842,1,HIV infection
18934893,189348932,2,F,2012,20210625,20210224,20210630,EXP,,US-GILEAD-2021-0517983,GILEAD,,,,A,F,Y,74.83,KG,20210630,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Bacterial infection;Depression;Diarrhoea;Emotional distress;Fungal infection;Neck pain;Osteopenia;Pain;Upper limb fracture;Wrist fracture,189348932,OT,,,189348932,1,2008,201811,,,189348932,1,HIV infection
18947791,189477912,2,F,,20210621,20210226,20210630,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053477,VIIV,,,,,M,Y,,,20210630,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189477912,OT,,,,,,,,,189477912,1,Product used for unknown indication
18947794,189477942,2,F,,20210621,20210226,20210630,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK053422,VIIV,,,,,M,Y,,,20210630,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189477942,OT,,,,,,,,,189477942,1,Product used for unknown indication
18947855,189478552,2,F,,20210621,20210226,20210630,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053422,GLAXOSMITHKLINE,,,,,M,Y,,,20210630,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189478552,OT,,,,,,,,,189478552,1,Product used for unknown indication
18947865,189478652,2,F,,20210621,20210226,20210630,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK053477,GLAXOSMITHKLINE,,,,,M,Y,,,20210630,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,189478652,DE,,,,,,,,,189478652,1,Product used for unknown indication
18957139,189571396,6,F,20201101,20210617,20210302,20210626,EXP,,PT-AUROBINDO-AUR-APL-2021-008814,AUROBINDO,,28,YR,,M,Y,92,KG,20210626,,PH,PT,PT,Efavirenz Aurovitas Film Coated Tablets,Anxiety;Headache;Hyperhidrosis,189571396,OT,,,189571396,1,20201101,,,,189571396,1,HIV infection
18987681,189876813,3,F,20201101,20210621,20210309,20210624,EXP,PT-INFARMED-F202102-1682,PT-GILEAD-2021-0519736,GILEAD,,28,YR,A,M,Y,92,KG,20210624,,PH,PT,PT,EFAVIRENZ AUROBINDO,Anxiety;Headache;Hyperhidrosis,189876813,OT,,,189876813,1,20201101,,,,189876813,1,HIV infection
19013877,190138772,2,F,,20210519,20210316,20210528,EXP,,CA-TEVA-2021-CA-1889881,TEVA,,54,YR,A,M,Y,,,20210528,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,190138772,OT,,,,,,,,,190138772,1,HIV infection
19019110,190191102,2,F,,20210520,20210316,20210528,EXP,,CA-TEVA-2021-CA-1890032,TEVA,,54,YR,A,M,Y,,,20210528,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,190191102,OT,,,,,,,,,190191102,1,HIV infection
19068707,190687073,3,F,201603,20210507,20210329,20210512,EXP,,US-009507513-2103USA007474,MERCK,,64,YR,,M,Y,,,20210512,,MD,US,US,efavirenz (+) emtricitabine (+) tenofovir disoproxil fumarate,Drug ineffective;Malignant neoplasm progression,190687073,DE,,,190687073,1,20151215,20160320,,,190687073,1,Neuroendocrine carcinoma of the skin
19080220,190802202,2,F,,20210326,20210401,20210403,EXP,,SE-AUROBINDO-AUR-APL-2021-013260,AUROBINDO,,36,YR,,M,Y,79,KG,20210403,,HP,SE,SE,Efavirenz Film?coated Tablet,Abnormal dreams;Coma;Erectile dysfunction,190802202,OT,,,,,,,,,190802202,1,HIV infection
19080233,190802335,5,F,,20210504,20210401,20210517,EXP,,SE-AUROBINDO-AUR-APL-2021-013259,AUROBINDO,,70,YR,,M,Y,75,KG,20210517,,HP,SE,SE,Efavirenz Film?coated Tablet,Diabetes mellitus;Fat redistribution;Labelled drug-drug interaction issue;Potentiating drug interaction;Sensory loss,190802335,OT,,,,,,,,,190802335,1,Product used for unknown indication
19081584,190815843,3,F,,20210607,20210331,20210615,EXP,,CA-ASTRAZENECA-2020SF04539,ASTRAZENECA,,44,YR,,M,Y,,,20210615,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,190815843,HO,,,,,,,,,190815843,1,Depression
19082861,190828611,1,I,,20130320,20210401,20210401,EXP,,ZA-MYLANLABS-13A-143-1070053-00,MYLAN,"ROSE, P.. LINEZOLID/VARIOUS DRUGS. REACTIONS WEEKLY. 2013?1445(1)",5,YR,,F,Y,,,20210401,,HP,ZA,ZA,EFAVIRENZ.,Aspartate aminotransferase increased;Hypothyroidism;Lactic acidosis;Neutropenia;Pancreatitis;Transaminases increased,190828611,HO,,,,,,,,,190828611,1,Tuberculosis
19087089,190870891,1,I,,20210330,20210402,20210402,EXP,,CA-ASTRAZENECA-2021A247703,ASTRAZENECA,,,,,M,Y,,,20210402,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190870891,DE,,,,,,,,,190870891,1,Product used for unknown indication
19089716,190897161,1,I,,20210331,20210403,20210403,EXP,,CA-ROCHE-2802799,ROCHE,,54,YR,,M,Y,,,20210403,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190897161,OT,,,,,,,,,190897161,1,Product used for unknown indication
19089720,190897201,1,I,,20210331,20210403,20210403,EXP,,CA-ROCHE-2802838,ROCHE,,54,YR,,M,Y,,,20210403,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,190897201,OT,,,,,,,,,190897201,1,Bipolar disorder
19094092,190940921,1,I,,20210330,20210405,20210405,EXP,,CA-ASTRAZENECA-2021A247691,ASTRAZENECA,,54,YR,,M,Y,,,20210405,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,190940921,OT,,,,,,,,,190940921,1,Product used for unknown indication
19094712,190947122,2,F,,20210408,20210406,20210416,EXP,,IT-CELLTRION INC.-2021IT004306,CELLTRION,"ALFANO G, GIARONI F, FONTANA F, NERI L, MOSCONI G, MUSSINI C, ET.AL.. RITUXIMAB IN PEOPLE LIVING WITH HIV AFFECTED BY IMMUNE?MEDIATED RENAL DISEASES: A CASE SERIES. INTERNATIONAL JOURNAL OF STD AND AIDS. 2020?1?6",,,,,Y,,,20210416,,HP,IT,IT,EFAVIRENZ.,CD4 lymphocytes decreased;CD8 lymphocytes decreased;Dyspnoea;Leukopenia;Neutropenia;Off label use;Pneumonia;Pneumonia bacterial;Product use in unapproved indication;Pyrexia,190947122,HO,,,190947122,1,201707,,,,190947122,1,Glomerulonephritis membranous
19095903,190959031,1,I,,20210331,20210406,20210406,EXP,,US-AUROBINDO-AUR-APL-2021-013621,AUROBINDO,,60,YR,,M,Y,,,20210406,,HP,US,US,EFAVIRENZ.,Cytomegalovirus infection;Cytomegalovirus infection reactivation;Malabsorption;Off label use,190959031,OT,,,,,,,,,190959031,1,HIV infection
19104565,191045651,1,I,,20210330,20210407,20210407,EXP,,CA-ASTRAZENECA-2021A242132,ASTRAZENECA,,54,YR,,M,Y,,,20210407,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,191045651,OT,,,,,,,,,191045651,1,Bipolar disorder
19117314,191173142,2,F,20201014,20210620,20210409,20210622,EXP,,CN-GILEAD-2021-0521065,GILEAD,,,,A,M,Y,50,KG,20210622,,HP,CN,CN,EFAVIRENZ.,Insomnia,191173142,DS,,,191173142,1,20200919,20201214,,,191173142,1,HIV infection
19118304,191183041,1,I,,20210329,20210409,20210409,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2021APC071715,VIIV,,33,YR,,M,Y,,,20210409,,MD,CN,CN,EFAVIRENZ.,Blood HIV RNA increased;Pathogen resistance;Virologic failure,191183041,OT,,,,,,,,,191183041,1,HIV infection
19118317,191183171,1,I,,20210329,20210409,20210409,EXP,,CN-GLAXOSMITHKLINE-CN2021APC071715,GLAXOSMITHKLINE,,33,YR,,M,Y,,,20210409,,MD,CN,CN,EFAVIRENZ.,Blood HIV RNA increased;Pathogen resistance;Virologic failure,191183171,OT,,,,,,,,,191183171,1,HIV infection
19118364,191183641,1,I,,20210408,20210409,20210409,EXP,GB-MHRA-EYC 00246831,GB-GILEAD-2021-0524732,GILEAD,,64,YR,A,M,Y,106,KG,20210409,,CN,GB,GB,EFAVIRENZ.,Weight increased,191183641,OT,,,191183641,1,20190101,,,,191183641,1,HIV infection
19126673,191266731,1,I,,20210407,20210412,20210412,EXP,,US-GILEAD-2021-0524885,GILEAD,,49,YR,A,M,Y,,,20210412,,HP,US,US,EFAVIRENZ.,Cytokine release syndrome;Diffuse large B-cell lymphoma;Immune effector cell-associated neurotoxicity syndrome;Neutrophil count decreased;Platelet count decreased,191266731,OT,,,,,,,,,191266731,1,Diffuse large B-cell lymphoma refractory
19131435,191314352,2,F,20210224,20210408,20210413,20210415,EXP,PT-INFARMED-E202103-1731,PT-GILEAD-2021-0524807,GILEAD,,40,YR,A,F,Y,,,20210415,,PH,PT,PT,EFAVIRENZ + EMTRICITABINA + TENOFOVIR TEVA,Dizziness;Insomnia;Malaise;Nausea;Vomiting,191314352,OT,,,191314352,1,20210224,20210224,,,191314352,1,HIV infection
19134529,191345291,1,I,,20210216,20210414,20210414,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK079642,VIIV,,54,YR,,M,Y,,,20210414,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,191345291,OT,,,,,,,,,191345291,1,Bipolar disorder
19134538,191345381,1,I,,20210216,20210414,20210414,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK079642,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210414,,CN,CA,CA,EFAVIRENZ.;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,191345381,OT,,,,,,,,,191345381,1,Bipolar disorder
19139533,191395331,1,I,,20210216,20210415,20210415,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK079651,GLAXOSMITHKLINE,,,,,M,Y,,,20210415,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,191395331,HO,,,,,,,,,191395331,1,Product used for unknown indication
19139535,191395351,1,I,,20210216,20210415,20210415,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK079651,VIIV,,,,,M,Y,,,20210415,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,191395351,HO,,,,,,,,,191395351,1,Product used for unknown indication
19139724,191397241,1,I,,20210402,20210415,20210415,EXP,,GB-MACLEODS PHARMACEUTICALS US LTD-MAC2021030774,MACLEODS,"NWAESEI AS, MOYE?DICKERSON PM, DRETLER RH. EFAVIRENZ?INDUCED VANISHING BILE DUCT SYNDROME: A CASE REPORT.. JOURNAL OF PHARMACY PRACTICE. 2021?34(2):319?324",,,,,Y,,,20210415,,HP,GB,GB,EFAVIRENZ.,Sepsis;Vanishing bile duct syndrome,191397241,HO,,,,,,,,,191397241,1,Antiretroviral therapy
19140898,191408981,1,I,,20210412,20210415,20210415,EXP,,CN-GILEAD-2021-0525100,GILEAD,,,,A,,Y,,,20210415,,MD,CN,CN,EFAVIRENZ.,Liver injury,191408981,OT,,,,,,,,,191408981,1,Acquired immunodeficiency syndrome
19142655,191426551,1,I,,20210407,20210416,20210416,EXP,,GB-AUROBINDO-AUR-APL-2021-015173,AUROBINDO,,58,YR,,F,Y,,,20210416,,CN,GB,GB,Efavirenz Film?coated Tablet,Suicidal ideation,191426551,OT,,,,,,,,,191426551,1,HIV infection
19143433,191434331,1,I,,20210406,20210416,20210416,EXP,,IR-MACLEODS PHARMACEUTICALS US LTD-MAC2021030786,MACLEODS,,,,,,Y,,,20210416,,CN,IN,IR,Emtricitabine/Efavirenz/Tenofovir disoproxil fumarate,Blood folate decreased;Blood lactate dehydrogenase increased;Thrombocytopenia,191434331,OT,,,,,,,,,191434331,1,Disseminated tuberculosis
19143926,191439261,1,I,,20210407,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900540,TEVA,,,,,M,Y,,,20210416,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction,191439261,OT,,,,,,,,,191439261,1,Product used for unknown indication
19143928,191439281,1,I,,20210407,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900809,TEVA,,,,,M,Y,,,20210416,,HP,CA,CA,EFAVIRENZ.,Depression;Drug interaction,191439281,OT,,,,,,,,,191439281,1,Product used for unknown indication
19145821,191458211,1,I,,20210407,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900832,TEVA,,,,,M,Y,,,20210416,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,191458211,OT,,,,,,,,,191458211,1,Product used for unknown indication
19149483,191494831,1,I,,20210407,20210417,20210417,EXP,,GB-MACLEODS PHARMA UK LTD-MAC2021030802,MACLEODS,,,,,,Y,,,20210417,,CN,GB,GB,EFAVIRENZ.,Suicidal ideation,191494831,OT,,,,,,,,,191494831,1,HIV infection
19151364,191513641,1,I,,20210413,20210419,20210419,EXP,,DE-GILEAD-2021-0525554,GILEAD,,,,,M,Y,,,20210419,,HP,DE,DE,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Hypophosphataemia;Renal salt-wasting syndrome,191513641,OT,,,191513641,1,200706,201704,,,191513641,1,HIV infection
19153691,191536911,1,I,,20210412,20210419,20210419,EXP,,ID-GILEAD-2021-0525429,GILEAD,"PUDJIATI S, RADIONO S, SOEBONO H, SISWATI A, WIROHADIDJOJO Y, KURNIAWATI C. SUCCESSFUL TREATMENT OF AIDS?ASSOCIATED TALAROMYCOSIS WITH LOW?DOSE ITRACONAZOLE. JAAD CASE REP.. 2020?6(12):1278?1280. DOI:10.1016/J.JDCR.2020.09.015",41,YR,A,M,Y,,,20210419,,MD,ID,ID,EFAVIRENZ.,Immune reconstitution inflammatory syndrome,191536911,OT,,,,,,,,,191536911,1,HIV infection
19153791,191537911,1,I,,20210216,20210419,20210419,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK079633,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210419,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,191537911,DE,,,,,,,,,191537911,1,Bipolar disorder
19153924,191539241,1,I,,20210216,20210419,20210419,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK079633,VIIV,,54,YR,,M,Y,,,20210419,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,191539241,OT,,,,,,,,,191539241,1,Bipolar disorder
19158456,191584563,3,F,202102,20210513,20210420,20210518,EXP,,GB-MYLANLABS-2021M1023515,MYLAN,,,,A,F,Y,,,20210518,,HP,GB,GB,EFAVIRENZ.,COVID-19;Product use issue;Pruritus;Skin disorder;Skin irritation;Skin ulcer,191584563,OT,,,,,,,,,191584563,1,Product used for unknown indication
19158544,191585441,1,I,2013,20200828,20210420,20210420,EXP,,US-VIIV HEALTHCARE LIMITED-US2020186935,VIIV,,,,,M,Y,83.9,KG,20210420,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Hypertension;Pain;Renal failure,191585441,OT,,,191585441,1,2013,2019,,,191585441,1,HIV infection
19158634,191586341,1,I,2013,20200828,20210420,20210420,EXP,,US-GLAXOSMITHKLINE-US2020186935,GLAXOSMITHKLINE,,,,,M,Y,83.9,KG,20210420,,CN,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Hypertension;Pain;Renal failure,191586341,OT,,,191586341,1,2013,2019,,,191586341,1,HIV infection
19159610,191596102,2,F,20210224,20210425,20210420,20210504,EXP,PT-INFARMED-E202103-1731,PT-TEVA-2021-PT-1901567,TEVA,,40,YR,A,F,Y,,,20210504,,PH,PT,PT,Efavirenz + Emtricitabina + Tenofovir Teva,Dizziness;Insomnia;Malaise;Nausea;Vomiting,191596102,OT,,,191596102,1,20210224,20210224,,,191596102,1,HIV infection
19161075,191610751,1,I,,20210408,20210421,20210421,PER,,IR-LUPIN PHARMACEUTICALS INC.-2021-04938,LUPIN,,35,YR,,M,Y,,,20210421,,HP,IR,IR,EFAVIRENZ.,Off label use;Thrombocytopenia,191610751,HO,,,,,,,,,191610751,1,Cerebral toxoplasmosis
19163624,191636241,1,I,,20210410,20210421,20210421,EXP,,AR-MACLEODS PHARMACEUTICALS US LTD-MAC2021030841,MACLEODS,"ONG AP, SIMS JL, NIEDERER RL. INFECTIOUS UVEITIS AFTER LOCAL STEROID AND/OR METHOTREXATE INJECTIONS AT A TERTIARY REFERRAL CENTER IN NEW ZEALAND: A CASE SERIES. OCULAR IMMUNOLOGY AND INFLAMMATION. 2021?1?5",,,,,Y,,,20210421,,HP,AR,AR,EFAVIRENZ.,Cytomegalovirus chorioretinitis;Cytomegalovirus infection reactivation,191636241,OT,,,,,,,,,191636241,1,Immune recovery uveitis
19169020,191690201,1,I,,20210412,20210422,20210422,EXP,,CA-TEVA-2021-CA-1901914,TEVA,,44,YR,A,M,Y,,,20210422,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,191690201,OT,,,,,,,,,191690201,1,HIV infection
19175835,191758351,1,I,,20210412,20210424,20210424,EXP,,IR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-037619,BRISTOL MYERS SQUIBB,"HAJSADEGHI S, IRANPOUR A, KALANTARI S, DASHTI F. A RARE MANIFESTATION OF EXTRAPULMONARY TUBERCULOSIS: LEFT VENTRICULAR CARDIAC TUBERCULOMA IN AN HIV INFECTED MALE ^CASE REPORT^. CARDIOVASCULAR DIAGNOSIS AND THERAPY. 2020?10(5):1341?4",37,YR,,M,Y,,,20210424,,HP,IR,IR,EFAVIRENZ.,Cardiac disorder;Pericardial effusion;Pleural effusion;Tuberculosis,191758351,OT,,,,,,,,,191758351,1,HIV infection
19178397,191783972,2,F,202102,20210513,20210426,20210607,EXP,,GB-AUROBINDO-AUR-APL-2021-016585,AUROBINDO,,,,A,F,Y,,,20210607,,HP,GB,GB,Efavirenz Film?coated Tablet,COVID-19;Product dose omission issue;Product use issue;Pruritus;Skin disorder;Skin irritation;Skin ulcer,191783972,OT,,,,,,,,,191783972,1,Product used for unknown indication
19179253,191792531,1,I,,20210413,20210426,20210426,PER,,IN-LUPIN PHARMACEUTICALS INC.-2021-05166,LUPIN,SINGH RK. AN UNUSUAL CAUSE OF SCIATICA IN AN IMMUNOCOMPROMISED PATIENT. BRITISH MEDICAL JOURNAL. 2021?372:N632:1?3,5,DEC,,F,Y,,,20210426,,MD,IN,IN,EFAVIRENZ.,Drug ineffective,,,,,,,,,,,191792531,1,Sciatica
19181946,191819461,1,I,,20210419,20210426,20210426,EXP,,CA-BAUSCH-BL-2021-014141,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210426,,HP,CA,CA,EFAVIRENZ.,Depression;Drug interaction;Loss of personal independence in daily activities,191819461,OT,,,,,,,,,191819461,1,Bipolar disorder
19181947,191819471,1,I,,20210419,20210426,20210426,EXP,,CA-BAUSCH-BL-2021-014140,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210426,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,191819471,OT,,,,,,,,,191819471,1,Bipolar disorder
19188833,191888331,1,I,202011,20201207,20210428,20210428,EXP,,ZA-MYLANLABS-2021M1024551,MYLAN,,31,YR,,M,Y,,,20210428,,CN,ZA,ZA,"EFAVIRENZ,EMTRICITABINE,TENOFOVIR MYLAN",Headache;Syncope,191888331,OT,,,191888331,2,202008,20201106,,,191888331,1,Product used for unknown indication
19192355,191923551,1,I,,20210419,20210429,20210429,EXP,,CA-AUROBINDO-AUR-APL-2021-016522,AUROBINDO,,54,YR,,M,Y,,,20210429,,HP,CA,CA,EFAVIRENZ.,Depression;Drug interaction;Loss of personal independence in daily activities,191923551,OT,,,,,,,,,191923551,1,HIV infection
19194327,191943271,1,I,,20210422,20210429,20210429,EXP,,US-GILEAD-2021-0527118,GILEAD,,60,YR,A,M,Y,,,20210429,,MD,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Osteoporosis;Renal failure,191943271,OT,,,191943271,1,2010,,,,191943271,1,HIV infection
19198418,191984182,2,F,,20210425,20210430,20210519,EXP,,CN-GILEAD-2021-0527089,GILEAD,LI LL. ANALYSIS AND RESEARCH ON THE CLINICAL EFFECTS AND ADVERSE REACTIONS OF AIDS PATIENTS TREATED WITH DIFFERENT ANTIVIRAL REGIMENS. WORLD JOURNAL OF COMPLEX MEDICINE. 2021?272:192?194. DOI:10.11966/J.ISSN.2095?994X. 2021.07.02.63,,,A,,Y,,,20210519,,MD,CN,CN,EFAVIRENZ.,Liver injury,191984182,OT,,,,,,,,,191984182,1,Acquired immunodeficiency syndrome
19198419,191984192,2,F,,20210425,20210430,20210519,EXP,,CN-GILEAD-2021-0527090,GILEAD,LI LL. ANALYSIS AND RESEARCH ON THE CLINICAL EFFECTS AND ADVERSE REACTIONS OF AIDS PATIENTS TREATED WITH DIFFERENT ANTIVIRAL REGIMENS. WORLD JOURNAL OF COMPLEX MEDICINE. 2021?272:192?194. DOI:10.11966/J.ISSN.2095?994X. 2021.07.02.63,,,A,,Y,,,20210519,,MD,CN,CN,EFAVIRENZ.,Renal injury,191984192,OT,,,,,,,,,191984192,1,Acquired immunodeficiency syndrome
19199998,191999981,1,I,,20210419,20210430,20210430,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK093546,VIIV,,54,YR,,M,Y,,,20210430,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,191999981,OT,,,,,,,,,191999981,1,Bipolar disorder
19200091,192000911,1,I,,20210419,20210430,20210430,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK093546,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210430,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,192000911,OT,,,,,,,,,192000911,1,Bipolar disorder
19203051,192030512,2,F,,20210427,20210503,20210507,EXP,,NL-AUROBINDO-AUR-APL-2017-15647,AUROBINDO,,56,YR,,F,Y,47,KG,20210507,,HP,NL,NL,EFAVIRENZ.,Amino acid level increased;Hepatic enzyme increased;Metabolic acidosis;Pyroglutamate increased,192030512,OT,,,,,,,,,192030512,1,Urinary tract infection
19204406,192044061,1,I,,20210419,20210503,20210503,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-039048,BRISTOL MYERS SQUIBB,,67,YR,,F,Y,79.38,KG,20210503,,HP,US,US,SUSTIVA,Anaphylactic reaction,192044061,OT,,,,,,,,,192044061,1,Acquired immunodeficiency syndrome
19207375,192073751,1,I,,20210420,20210503,20210503,EXP,,NL-PERRIGO-08NL017603,PERRIGO,"KORTMANN W, VAN AGTMAEL MA, VAN DIESSEN J, KANEN BLJ, JAKOBS C, NANAYAKKARA PWB. 5?OXOPROLINE AS A CAUSE OF HIGH ANION GAP METABOLIC ACIDOSIS: AN UNCOMMON CAUSE WITH COMMON RISK FACTORS. NETH J MED. 2008?66 (8):354?7",,,,,Y,,,20210503,,HP,NL,NL,EFAVIRENZ.,Metabolic acidosis;Pyroglutamate increased,192073751,OT,,,,,,,,,192073751,1,Urinary tract infection
19208184,192081841,1,I,,20210419,20210503,20210503,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2021GSK093641,VIIV,,54,YR,,M,Y,,,20210503,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction;Loss of personal independence in daily activities,192081841,OT,,,,,,,,,192081841,1,Bipolar disorder
19208192,192081921,1,I,,20210419,20210503,20210503,EXP,,CA-GLAXOSMITHKLINE-CA2021GSK093641,GLAXOSMITHKLINE,,54,YR,,M,Y,,,20210503,,CN,CA,CA,EFAVIRENZ.,Depression;Drug interaction;Loss of personal independence in daily activities,192081921,OT,,,,,,,,,192081921,1,Bipolar disorder
19212064,192120641,1,I,,20210427,20210504,20210504,EXP,,US-VIIV HEALTHCARE LIMITED-US2021AMR093228,VIIV,,,,,F,Y,79.38,KG,20210504,,CN,US,US,SUSTIVA,Anaphylactic reaction;Throat tightness;Thyroiditis;Urticaria,192120641,OT,,,192120641,3,2003,,,,192120641,1,Acquired immunodeficiency syndrome
19212598,192125981,1,I,20210408,20210422,20210504,20210504,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-039386,BRISTOL MYERS SQUIBB,,27,YR,,M,Y,75,KG,20210504,,CN,FR,FR,EFAVIRENZ.,Confusional state;Loss of consciousness;Nausea;Pruritus;Pyrexia;Vertigo,192125981,OT,,,192125981,1,20210401,,,,192125981,1,Prophylaxis against HIV infection
19224918,192249181,1,I,20210408,20210427,20210506,20210506,EXP,FR-AFSSAPS-PB20212147,FR-TEVA-2021-FR-1907478,TEVA,,27,YR,A,M,Y,75,KG,20210506,,CN,FR,FR,EFAVIRENZ.,Confusional state;Loss of consciousness;Nausea;Pruritus;Pyrexia;Vertigo,192249181,OT,,,192249181,1,20210401,20210410,,,192249181,1,Prophylaxis against HIV infection
19225328,192253281,1,I,,20210429,20210506,20210506,EXP,,CA-ROCHE-2822133,ROCHE,,54,YR,,M,Y,,,20210506,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,192253281,OT,,,,,,,,,192253281,1,Bipolar disorder
19225652,192256521,1,I,,20210429,20210506,20210506,EXP,,CA-ROCHE-2822551,ROCHE,,54,YR,,M,Y,,,20210506,,HP,CA,CA,EFAVIRENZ.,Depression;Drug interaction;Loss of personal independence in daily activities,192256521,OT,,,,,,,,,192256521,1,Bipolar disorder
19228048,192280483,3,F,202007,20210527,20210506,20210603,EXP,,AR-ORGANON-O2105ARG000146,ORGANON,,28,YR,,F,Y,,,20210603,,CN,AR,AR,EFAVIRENZ + EMTRICITABINE + TENOFOVIR [EFAVIRENZ;EMTRICITABINE;TENOFOV,Abortion induced;Inappropriate schedule of product administration;Pregnancy with implant contraceptive;Unintended pregnancy,192280483,HO,,,192280483,1,202007,20210427,,,192280483,2,HIV infection
19243372,192433721,1,I,,20210505,20210511,20210511,EXP,,TH-MYLANLABS-2021M1027841,MYLAN,,27,YR,,F,Y,,,20210511,,HP,TH,TH,EFAVIRENZ.,Drug resistance,192433721,OT,,,192433721,5,2000,,,,192433721,1,HIV infection
19243388,192433881,1,I,,20210505,20210511,20210511,EXP,,TH-MYLANLABS-2021M1027843,MYLAN,,35,YR,,M,Y,,,20210511,,HP,TH,TH,EFAVIRENZ.,Drug resistance,192433881,OT,,,192433881,1,2009,,,,192433881,1,HIV infection
19248500,192485001,1,I,,20210505,20210512,20210512,EXP,,TH-MYLANLABS-2021M1027839,MYLAN,,24,YR,,M,Y,,,20210512,,HP,TH,TH,EFAVIRENZ.,Drug resistance,192485001,OT,,,192485001,1,2015,,,,192485001,1,HIV infection
19250133,192501331,1,I,,20210505,20210512,20210512,EXP,,TH-MYLANLABS-2021M1027840,MYLAN,,35,YR,,F,Y,,,20210512,,HP,TH,TH,EFAVIRENZ.,Drug resistance,192501331,OT,,,192501331,1,2000,,,,192501331,1,HIV infection
19250147,192501471,1,I,,20210505,20210512,20210512,EXP,,TH-MYLANLABS-2021M1027844,MYLAN,,57,YR,,M,Y,,,20210512,,HP,TH,TH,EFAVIRENZ.,Drug resistance,192501471,OT,,,192501471,1,2013,,,,192501471,1,Acquired immunodeficiency syndrome
19250157,192501571,1,I,,20210505,20210512,20210512,EXP,,TH-MYLANLABS-2021M1027845,MYLAN,,35,YR,,F,Y,,,20210512,,HP,TH,TH,EFAVIRENZ.,Drug resistance,192501571,OT,,,192501571,1,2007,,,,192501571,1,HIV infection
19256891,192568911,1,I,,20210510,20210514,20210514,EXP,,IN-AUROBINDO-AUR-APL-2021-019684,AUROBINDO,,,,,,Y,,,20210514,,HP,IN,IN,Tenofovir+Lamivudine+Efavirenz,Acute kidney injury;Renal tubular disorder,192568911,OT,,,,,,,,,192568911,1,HIV infection
19258173,192581731,1,I,2006,20210512,20210514,20210514,EXP,,US-GILEAD-2021-0530516,GILEAD,,,,A,F,Y,,,20210514,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Cerebral disorder;Cerebrovascular accident,192581731,OT,,,,,,,,,192581731,1,HIV infection
19258363,192583631,1,I,,20210505,20210514,20210514,EXP,,JP-VIIV HEALTHCARE LIMITED-VN2021GSK102373,VIIV,"KINAI E, NGUYEN HDT, DO HQ, MATSUMOTO S, NAGAI M, TANUMA J ET AL. INFLUENCE OF MATERNAL USE OF TENOFOVIR DISOPROXIL FUMARATE OR ZIDOVUDINE IN VIETNAMESE PREGNANT WOMEN WITH HIV ON INFANT GROWTH, RENAL FUNCTION, AND BONE HEALTH. PLOS ONE. 2021?16(4)",12,MON,,F,Y,9,KG,20210514,,HP,JP,VN,EFAVIRENZ.,Bone disorder;Foetal exposure during pregnancy;Live birth;Rickets,192583631,OT,,,192583631,1,20161227,,,,192583631,1,HIV infection
19258369,192583691,1,I,,20210505,20210514,20210514,EXP,,JP-GLAXOSMITHKLINE-VN2021GSK102373,GLAXOSMITHKLINE,"KINAI E, NGUYEN HDT, DO HQ, MATSUMOTO S, NAGAI M, TANUMA J ET AL. INFLUENCE OF MATERNAL USE OF TENOFOVIR DISOPROXIL FUMARATE OR ZIDOVUDINE IN VIETNAMESE PREGNANT WOMEN WITH HIV ON INFANT GROWTH, RENAL FUNCTION, AND BONE HEALTH. PLOS ONE. 2021?16(4)",12,MON,,F,Y,9,KG,20210514,,HP,JP,VN,EFAVIRENZ.,Bone disorder;Foetal exposure during pregnancy;Live birth;Rickets,192583691,OT,,,192583691,1,20161227,,,,192583691,1,HIV infection
19259682,192596821,1,I,202011,20210209,20210514,20210514,PER,,UG-POPULATION COUNCIL-2021TPC000022,POPULATION COUNCIL,,33,YR,A,F,Y,,,20210511,,CN,UG,UG,EFAVIRENZ.,Drug ineffective;Labelled drug-drug interaction medication error;Pregnancy with implant contraceptive,192596821,OT,,,192596821,1,20190518,20210203,,,192596821,1,Contraception
19261486,192614861,1,I,,20180108,20210515,20210515,EXP,,US-AUROBINDO-AUR-APL-2018-002422,AUROBINDO,,25,YR,,M,Y,,,20210515,,HP,US,US,Efavirenz + emtricitabine + tenofovir disoproxil fumarate,Enteritis;Mucosal inflammation,192614861,OT,,,,,,,,,192614861,1,Diffuse large B-cell lymphoma stage IV
19264810,192648101,1,I,2004,20210504,20210517,20210517,EXP,,ES-AUROBINDO-AUR-APL-2021-019110,AUROBINDO,"JOVER, F ET AL. SIMPLIFICACI?N DEL TRATAMIENTO ANTIRRETROVIRAL. N/A. N/A?N/A:N/A",66,YR,,M,Y,,,20210517,,MD,ES,ES,EFAVIRENZ.,Drug ineffective;Treatment failure,192648101,OT,,,,,,,,,192648101,1,HIV infection
19266013,192660131,1,I,,20210505,20210518,20210518,EXP,,TH-LUPIN PHARMACEUTICALS INC.-2021-07051,LUPIN,,27,YR,,F,Y,,,20210518,,HP,TH,TH,EFAVIRENZ.,Drug resistance,192660131,OT,,,192660131,3,2000,,,,192660131,1,HIV infection
19266019,192660191,1,I,,20210505,20210518,20210518,EXP,,TH-LUPIN PHARMACEUTICALS INC.-2021-07052,LUPIN,,35,YR,,F,Y,,,20210518,,HP,TH,TH,EFAVIRENZ.,Drug resistance,192660191,OT,,,192660191,1,2007,,,,192660191,1,HIV infection
19266022,192660221,1,I,,20210505,20210518,20210518,EXP,,TH-LUPIN PHARMACEUTICALS INC.-2021-07057,LUPIN,,24,YR,,M,Y,,,20210518,,HP,TH,TH,EFAVIRENZ.,Drug resistance,192660221,OT,,,192660221,1,2015,,,,192660221,1,HIV infection
19267062,192670621,1,I,,20210505,20210517,20210517,EXP,,CA-GLAXOSMITHKLINE-TZ2021GSK097454,GLAXOSMITHKLINE,,10,YR,,F,Y,,,20210517,,HP,TZ,TZ,EFAVIRENZ.,Anaemia;Cytopenia;Histoplasmosis;Immunosuppression;Malnutrition;Pyrexia;Skin induration;Skin mass;Skin plaque;Skin ulcer;Treatment noncompliance;Virologic failure;Weight decreased,192670621,HO,,,192670621,1,,2016,,,192670621,1,Antiretroviral therapy
19267064,192670641,1,I,,20210505,20210517,20210517,EXP,,CA-VIIV HEALTHCARE LIMITED-TZ2021GSK097454,VIIV,,10,YR,,F,Y,,,20210517,,HP,TZ,TZ,EFAVIRENZ.,Anaemia;Cytopenia;Histoplasmosis;Immunosuppression;Malnutrition;Pyrexia;Skin induration;Skin mass;Skin plaque;Skin ulcer;Treatment noncompliance;Virologic failure;Weight decreased,192670641,OT,,,192670641,1,,2016,,,192670641,1,Antiretroviral therapy
19275538,192755381,1,I,,20210505,20210519,20210519,EXP,,TH-LUPIN PHARMACEUTICALS INC.-2021-07056,LUPIN,,57,YR,,M,Y,,,20210519,,HP,TH,TH,EFAVIRENZ.,Drug resistance,192755381,OT,,,192755381,1,2013,,,,192755381,1,HIV infection
19275788,192757881,1,I,,20210505,20210519,20210519,EXP,,TH-LUPIN PHARMACEUTICALS INC.-2021-07050,LUPIN,,35,YR,,F,Y,,,20210519,,HP,TH,TH,EFAVIRENZ.,Drug resistance,192757881,OT,,,192757881,1,2000,,,,192757881,1,HIV infection
19280502,192805021,1,I,2004,20210512,20210521,20210521,EXP,,PT-AUROBINDO-AUR-APL-2021-020213,AUROBINDO,,55,YR,,F,Y,,,20210521,,MD,PT,PT,Efavirenz Film?coated Tablet,Major depression;Neuropathy peripheral,192805021,OT,,,192805021,1,2011,2014,,,192805021,1,HIV infection
19283608,192836081,1,I,,20210517,20210520,20210520,EXP,,AU-ABBVIE-21K-008-3910030-00,ABBVIE,,52,YR,,F,Y,,,20210520,,CN,AU,AU,EFAVIRENZ.,Behaviour disorder;Central nervous system inflammation;Cerebellar syndrome;Chorea;Confusional state;Disorientation;Dysarthria;Dysdiadochokinesis;Gait disturbance;HIV-associated neurocognitive disorder;Hypophagia;Loss of personal independence in daily activities;Magnetic resonance imaging head abnormal;Meningitis viral;Meningoencephalitis viral;Parainfluenzae virus infection;Past-pointing;Pathogen resistance;Rhinitis;Treatment noncompliance,192836081,OT,,,,,,,,,192836081,1,Product used for unknown indication
19298373,192983731,1,I,20200125,20210512,20210525,20210525,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-07708,LUPIN,,38,YR,,M,Y,,,20210525,,HP,CN,CN,EFAVIRENZ.,Off label use,192983731,OT,,,192983731,1,20200125,,,,192983731,1,Suspected COVID-19
19301800,193018001,1,I,,20210510,20210525,20210525,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-047350,BRISTOL MYERS SQUIBB,"BHATTACHARYA D, GUPTA A, TIERNEY C, HUANG S, PETERS MG, CHIPATO T, ET AL. HEPATOTOXICITY AND LIVER?RELATED MORTALITY IN WOMEN OF CHILDBEARING POTENTIAL LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS AND HIGH CD4 CELL COUNTS INITIATING EFAVIRENZ?CONTAINING REGIMENS. CLINICAL INFECTIOUS DISEASES. 2021?72(8):1342?9",,,A,F,Y,,,20210525,,HP,US,US,EFAVIRENZ.,Hepatitis,193018001,DE,,,,,,,,,193018001,1,HIV infection
19301842,193018421,1,I,,20210510,20210525,20210525,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-050670,BRISTOL MYERS SQUIBB,"BHATTACHARYA D, GUPTA A, TIERNEY C, HUANG S, PETERS MG, CHIPATO T, ET AL. HEPATOTOXICITY AND LIVER?RELATED MORTALITY IN WOMEN OF CHILDBEARING POTENTIAL LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS AND HIGH CD4 CELL COUNTS INITIATING EFAVIRENZ?CONTAINING REGIMENS. CLINICAL INFECTIOUS DISEASES. 2021?72(8):1342?9",,,A,F,Y,,,20210525,,HP,US,US,EFAVIRENZ.,Hepatitis,193018421,OT,,,,,,,,,193018421,1,HIV infection
19305581,193055811,1,I,,20210519,20210526,20210526,EXP,,GB-GILEAD-2021-0531497,GILEAD,,,,A,F,Y,,,20210526,,CN,GB,GB,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Cardiac disorder,193055811,HO,,,,,,,,,193055811,1,Product used for unknown indication
19305993,193059931,1,I,,20210514,20210526,20210526,EXP,,CN-CIPLA LTD.-2021CN03687,CIPLA,,,,,,Y,,,20210526,,HP,CN,CN,EFAVIRENZ.,Drug resistance,193059931,OT,,,,,,,,,193059931,1,Acquired immunodeficiency syndrome
19307378,193073781,1,I,20210520,20210521,20210526,20210526,EXP,,US-GILEAD-2021-0532524,GILEAD,,43,YR,A,F,Y,,,20210526,,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Brain neoplasm;Dementia;Gait inability;Renal cyst;Spinal disorder,193073781,OT,,,,,,,,,193073781,1,HIV infection
19309038,193090381,1,I,,20210518,20210525,20210525,EXP,,GB-VIIV HEALTHCARE LIMITED-GB2021GSK110708,VIIV,,23,YR,,F,Y,,,20210525,,MD,GB,GB,EFAVIRENZ.,Pathogen resistance;Treatment noncompliance;Viral mutation identified;Virologic failure,193090381,OT,,,193090381,1,20180111,,,,193090381,1,HIV infection
19310362,193103621,1,I,,20210518,20210526,20210526,EXP,,CN-GLAXOSMITHKLINE-CN2021APC104723,GLAXOSMITHKLINE,,,,,,Y,,,20210526,,HP,CN,CN,EFAVIRENZ.,Chronic kidney disease,193103621,OT,,,,,,,,,193103621,1,HIV infection
19311081,193110811,1,I,,20210518,20210527,20210527,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2021APC104723,VIIV,,,,,,Y,,,20210526,,HP,CN,CN,EFAVIRENZ.,Chronic kidney disease,193110811,OT,,,,,,,,,193110811,1,HIV infection
19312818,193128181,1,I,,20210517,20210527,20210527,EXP,,CA-APOTEX-2021AP012394,APOTEX,,,,,M,Y,,,20210527,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,193128181,HO,,,,,,,,,193128181,1,Product used for unknown indication
19314076,193140761,1,I,,20210518,20210527,20210527,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2021GSK112037,VIIV,,,,,,Y,,,20210527,,HP,CN,CN,EFAVIRENZ.,Chronic kidney disease,193140761,OT,,,,,,,,,193140761,1,HIV infection
19314084,193140841,1,I,,20210518,20210527,20210527,EXP,,CN-GLAXOSMITHKLINE-CN2021GSK112037,GLAXOSMITHKLINE,,,,,,Y,,,20210527,,HP,CN,CN,EFAVIRENZ.,Chronic kidney disease,193140841,OT,,,,,,,,,193140841,1,HIV infection
19330723,193307231,1,I,,20210521,20210528,20210528,PER,,NG-LUPIN PHARMACEUTICALS INC.-2021-08419,LUPIN,,10,YR,,M,Y,,,20210529,,HP,NG,NG,EFAVIRENZ.,Impaired fasting glucose,,,,,,,,,,,193307231,1,HIV infection
19350179,193501791,1,I,20190909,,20210531,20210531,DIR,,,FDA-CTU,,28,YR,,M,N,63,KG,20210531,N,CN,PE,PE,AVONZA (EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE);EFAVIRENZ.,Dizziness;Dysphagia;Pruritus;Rash macular;Tachycardia,193501791,DS,193501791,FGN,193501791,1,20190831,,,,193501791,1,HIV infection
19352075,193520751,1,I,,20210517,20210531,20210531,EXP,,CN-GLAXOSMITHKLINE-CN2021111926,GLAXOSMITHKLINE,,38,YR,,,Y,,,20210531,,HP,CN,CN,EFAVIRENZ.,Drug resistance;Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,193520751,OT,,,193520751,1,201410,201411,,,193520751,1,HIV infection
19352099,193520991,1,I,,20210517,20210531,20210531,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2021111926,VIIV,,38,YR,,,Y,,,20210531,,HP,CN,CN,EFAVIRENZ.,Drug resistance;Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,193520991,OT,,,193520991,1,201410,201411,,,193520991,1,HIV infection
19359425,193594251,1,I,,20210528,20210602,20210602,EXP,,GB-MYLANLABS-2021M1031866,MYLAN,,23,YR,,F,Y,,,20210602,,MD,GB,GB,EFAVIRENZ.,Pathogen resistance;Treatment noncompliance;Viral mutation identified;Virologic failure,193594251,OT,,,193594251,1,20180111,,,,193594251,1,HIV infection
19359763,193597631,1,I,,20210528,20210601,20210601,EXP,,GB-MYLANLABS-2021M1031870,MYLAN,,,,A,F,Y,,,20210601,,CN,GB,GB,EFAVIRENZ.,Cardiac disorder,193597631,HO,,,,,,,,,193597631,1,Product used for unknown indication
19364447,193644471,1,I,,20210521,20210602,20210602,PER,,NG-LUPIN PHARMACEUTICALS INC.-2021-08420,LUPIN,,13,YR,,F,Y,,,20210602,,HP,CI,NG,EFAVIRENZ.,Impaired fasting glucose,,,,,,,,,,,193644471,1,HIV infection
19364448,193644481,1,I,,20210521,20210602,20210602,PER,,NG-LUPIN PHARMACEUTICALS INC.-2021-08421,LUPIN,,14,YR,,F,Y,,,20210602,,HP,CI,NG,EFAVIRENZ.,Impaired fasting glucose,,,,,,,,,,,193644481,1,HIV infection
19375558,193755581,1,I,,20210528,20210604,20210604,EXP,,GB-VIIV HEALTHCARE LIMITED-GB2021EME116426,VIIV,,62,YR,,M,Y,,,20210604,,CN,GB,GB,EFAVIRENZ.,Renal impairment,193755581,OT,,,193755581,1,20150301,,,,193755581,1,HIV infection
19375560,193755601,1,I,,20210528,20210604,20210604,EXP,,GB-VIIV HEALTHCARE LIMITED-GB2021EME116388,VIIV,,65,YR,,M,Y,,,20210604,,CN,GB,GB,EFAVIRENZ + EMTRICITABINE + TENOFOVIR;EFAVIRENZ.,Renal impairment,193755601,OT,,,193755601,1,20120601,,,,193755601,1,HIV infection
19377487,193774872,2,F,,20210531,20210604,20210609,EXP,,US-GILEAD-2021-0534438,GILEAD,"CHINULA L., BRUMMEL S., ZIEMBA L., MCCARTHY K., JOHNSTON B., CHAKHTOURA N., ET AL. SAFETY/EFFICACY OF DTG VS EFV, TDF VS TAF IN PREGNANCY/ POSTPARTUM: IMPAACT 2010 TRIAL.. TOPICS IN ANTIVIRAL MEDICINE.. 2021?29(1):56",,,I,,Y,,,20210609,,HP,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Congenital anomaly;Foetal exposure during pregnancy,193774872,CA,,,,,,,,,193774872,1,HIV infection
19377488,193774882,2,F,,20210531,20210604,20210609,EXP,,US-GILEAD-2021-0534437,GILEAD,"CHINULA L., BRUMMEL S., ZIEMBA L., MCCARTHY K., JOHNSTON B., CHAKHTOURA N., ET AL. SAFETY/EFFICACY OF DTG VS EFV, TDF VS TAF IN PREGNANCY/ POSTPARTUM: IMPAACT 2010 TRIAL.. TOPICS IN ANTIVIRAL MEDICINE.. 2021?29(1):56",,,I,,Y,,,20210609,,HP,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Congenital anomaly;Foetal exposure during pregnancy,193774882,CA,,,,,,,,,193774882,1,HIV infection
19379068,193790681,1,I,,20210528,20210607,20210607,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052827,BRISTOL MYERS SQUIBB,,,,A,F,Y,,,20210607,,CN,GB,GB,EFAVIRENZ.,Cardiac disorder,193790681,HO,,,,,,,,,193790681,1,Product used for unknown indication
19380179,193801791,1,I,,20210528,20210607,20210607,EXP,,GB-AUROBINDO-AUR-APL-2021-022937,AUROBINDO,,23,YR,,F,Y,,,20210607,,MD,GB,GB,EFAVIRENZ.,Pathogen resistance;Treatment noncompliance;Viral mutation identified;Virologic failure,193801791,OT,,,193801791,1,20180111,,,,193801791,1,HIV infection
19380222,193802221,1,I,,20210528,20210607,20210607,EXP,,GB-AUROBINDO-AUR-APL-2021-022866,AUROBINDO,,,,A,F,Y,,,20210607,,CN,GB,GB,Efavirenz Film?coated Tablet,Cardiac disorder,193802221,HO,,,,,,,,,193802221,1,Product used for unknown indication
19381264,193812641,1,I,,20210601,20210607,20210607,EXP,,US-GLAXOSMITHKLINE-US2021GSK121574,GLAXOSMITHKLINE,,,,,,Y,,,20210607,,HP,US,US,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,193812641,OT,,,,,,,,,193812641,1,HIV infection
19381265,193812651,1,I,,20210601,20210607,20210607,EXP,,US-VIIV HEALTHCARE LIMITED-US2021GSK121574,VIIV,,,,,,Y,,,20210607,,HP,US,US,EFAVIRENZ.,Pathogen resistance;Viral mutation identified;Virologic failure,193812651,OT,,,,,,,,,193812651,1,HIV infection
19382398,193823981,1,I,,20210528,20210607,20210607,EXP,,US-VIIV HEALTHCARE LIMITED-US2021AMR116356,VIIV,,30,YR,,F,Y,,,20210607,,CN,US,US,EFAVIRENZ.,Weight increased,,,,,,,,,,,193823981,1,Product used for unknown indication
19382400,193824001,1,I,,20210528,20210607,20210607,EXP,,US-GLAXOSMITHKLINE-US2021AMR116356,GLAXOSMITHKLINE,,30,YR,,F,Y,,,20210607,,CN,US,US,EFAVIRENZ.,Weight increased,,,,,,,,,,,193824001,1,Product used for unknown indication
19383558,193835581,1,I,,20210528,20210608,20210608,EXP,,GB-MACLEODS PHARMA UK LTD-MAC2021031349,MACLEODS,,,,,,Y,,,20210607,,CN,GB,GB,EFAVIRENZ.,Cardiac disorder,193835581,HO,,,,,,,,,193835581,1,Product used for unknown indication
19386144,193861441,1,I,,20210531,20210608,20210608,EXP,,US-GILEAD-2021-0534459,GILEAD,"HOFFMAN R, ZIEMBA L, BRUMMEL S, CHINULA L, NEMATADZIRA T, NAKAYIWA F, STRINGER J, KROTJE C, JEAN?PHILIPPE P, COLETTI A, ZASH R, SHAPIRO R, SAX P, CURRIER J, LOCKMAN S. ANTEPARTUM WEIGHT GAIN AND ADVERSE PREGNANCY OUTCOMES IN IMPAACT 2010. UNK. 2021?29 (1):55?56",,,I,,Y,,,20210608,,HP,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Foetal exposure during pregnancy;Stillbirth,193861441,OT,,,,,,,,,193861441,1,HIV infection
19389493,193894931,1,I,,20210531,20210608,20210608,EXP,,US-GILEAD-2021-0534458,GILEAD,"HOFFMAN R, ZIEMBA L, BRUMMEL S, CHINULA L, NEMATADZIRA T, NAKAYIWA F, STRINGER J, KROTJE C, JEAN?PHILIPPE P, COLETTI A, ZASH R, SHAPIRO R, SAX P, CURRIER J, LOCKMAN S. ANTEPARTUM WEIGHT GAIN AND ADVERSE PREGNANCY OUTCOMES IN IMPAACT 2010. UNK. 2021?29 (1):55?56",,,I,,Y,,,20210608,,HP,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Foetal exposure during pregnancy;Stillbirth,193894931,OT,,,,,,,,,193894931,1,HIV infection
19391015,193910151,1,I,,20210606,20210609,20210609,EXP,,GB-ABBVIE-21K-167-3938458-00,ABBVIE,,62,YR,,M,Y,,,20210608,,CN,GB,GB,EFAVIRENZ.,Renal impairment,193910151,OT,,,193910151,1,20150301,,,,193910151,1,HIV infection
19392241,193922411,1,I,,20210531,20210608,20210608,EXP,,US-GILEAD-2021-0534457,GILEAD,"HOFFMAN R, ZIEMBA L, BRUMMEL S, CHINULA L, NEMATADZIRA T, NAKAYIWA F, STRINGER J, KROTJE C, JEAN?PHILIPPE P, COLETTI A, ZASH R, SHAPIRO R, SAX P, CURRIER J, LOCKMAN S. ANTEPARTUM WEIGHT GAIN AND ADVERSE PREGNANCY OUTCOMES IN IMPAACT 2010. UNK. 2021?29 (1):55?56",,,I,,Y,,,20210608,,HP,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Foetal exposure during pregnancy;Small for dates baby,193922411,OT,,,,,,,,,193922411,1,HIV infection
19393178,193931781,1,I,,20210607,20210609,20210609,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-055682,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210609,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,193931781,DE,,,,,,,,,193931781,1,Product used for unknown indication
19394934,193949341,1,I,,20210528,20210609,20210609,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052814,BRISTOL MYERS SQUIBB,,23,YR,,F,Y,,,20210609,,MD,GB,GB,EFAVIRENZ.,Pathogen resistance;Treatment noncompliance;Viral mutation identified;Virologic failure,193949341,OT,,,193949341,1,20180111,,,,193949341,1,HIV infection
19395246,193952461,1,I,,20210602,20210609,20210609,EXP,,GB-VIIV HEALTHCARE LIMITED-GB2021EME123104,VIIV,,76,YR,,M,Y,,,20210609,,CN,GB,GB,EFAVIRENZ + EMTRICITABINE + TENOFOVIR,Renal impairment,193952461,OT,,,193952461,1,20121101,,,,193952461,1,HIV infection
19395845,193958451,1,I,,20210607,20210609,20210609,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-055868,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210609,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,193958451,OT,,,,,,,,,193958451,1,Product used for unknown indication
19396371,193963711,1,I,,20210602,20210609,20210609,EXP,,GB-VIIV HEALTHCARE LIMITED-GB2021EME123182,VIIV,,61,YR,,M,Y,,,20210609,,CN,GB,GB,EFAVIRENZ + EMTRICITABINE + TENOFOVIR,Renal impairment,193963711,OT,,,193963711,1,20121101,,,,193963711,1,HIV infection
19396429,193964291,1,I,,20210607,20210610,20210610,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-055869,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210610,,HP,CA,CA,SUSTIVA,Depression,193964291,DE,,,,,,,,,193964291,1,Product used for unknown indication
19397542,193975421,1,I,,20210531,20210610,20210610,EXP,,ET-AUROBINDO-AUR-APL-2021-023210,AUROBINDO,,55,YR,,M,Y,,,20210610,,HP,ET,ET,EFAVIRENZ.,Cholestatic liver injury,193975421,OT,,,,,,,,,193975421,1,Product used for unknown indication
19397700,193977001,1,I,,20210607,20210609,20210609,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-056021,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210609,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,193977001,OT,,,,,,,,,193977001,1,HIV infection
19397735,193977351,1,I,,20210606,20210610,20210610,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-055188,BRISTOL MYERS SQUIBB,,62,YR,,M,Y,,,20210610,,MD,GB,GB,EFAVIRENZ.,Renal impairment,193977351,OT,,,193977351,1,20150301,,,,193977351,1,HIV infection
19399611,193996111,1,I,,20210606,20210610,20210610,EXP,,GB-MYLANLABS-2021M1033517,MYLAN,,62,YR,,M,Y,,,20210610,,CN,GB,GB,EFAVIRENZ.,Renal impairment,193996111,OT,,,193996111,1,20150301,,,,193996111,1,HIV infection
19399734,193997341,1,I,,20210607,20210610,20210610,EXP,,FR-MYLANLABS-2021M1033868,MYLAN,,,,A,M,Y,,,20210610,,MD,FR,FR,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Drug ineffective;Drug interaction;Viral load increased,193997341,OT,,,,,,,,,193997341,1,HIV infection
19401215,194012151,1,I,,20210528,20210611,20210611,EXP,,GB-CIPLA LTD.-2021GB03954,CIPLA,,,,,,Y,,,20210611,,HP,GB,GB,EFAVIRENZ.,Cardiac disorder,194012151,HO,,,,,,,,,194012151,1,Product used for unknown indication
19401235,194012351,1,I,,20210531,20210611,20210611,EXP,,ET-AUROBINDO-AUR-APL-2021-023203,AUROBINDO,,25,YR,,F,Y,,,20210611,,HP,SE,ET,EFAVIRENZ.,Drug-induced liver injury,194012351,OT,,,,,,,,,194012351,1,HIV infection
19401260,194012601,1,I,,20210531,20210611,20210611,EXP,,ET-AUROBINDO-AUR-APL-2021-023205,AUROBINDO,,45,YR,,M,Y,,,20210611,,HP,SE,ET,EFAVIRENZ.,Drug-induced liver injury,194012601,OT,,,,,,,,,194012601,1,HIV infection
19401277,194012771,1,I,,20210531,20210611,20210611,EXP,,ET-AUROBINDO-AUR-APL-2021-023209,AUROBINDO,,28,YR,,F,Y,,,20210611,,HP,SE,ET,EFAVIRENZ.,Cholestatic liver injury,194012771,OT,,,,,,,,,194012771,1,HIV infection
19401300,194013001,1,I,,20210531,20210611,20210611,EXP,,ET-AUROBINDO-AUR-APL-2021-023212,AUROBINDO,,30,YR,,F,Y,,,20210611,,HP,SE,ET,EFAVIRENZ.,Drug-induced liver injury,194013001,OT,,,,,,,,,194013001,1,HIV infection
19401328,194013281,1,I,,20210531,20210611,20210611,EXP,,ET-AUROBINDO-AUR-APL-2021-023214,AUROBINDO,,30,YR,,F,Y,,,20210611,,HP,SE,ET,EFAVIRENZ.,Cholestatic liver injury,194013281,OT,,,,,,,,,194013281,1,Product used for unknown indication
19401360,194013601,1,I,,20210531,20210611,20210611,EXP,,ET-AUROBINDO-AUR-APL-2021-023215,AUROBINDO,,30,YR,,F,Y,,,20210611,,HP,SE,ET,EFAVIRENZ.,Cholestatic liver injury,194013601,OT,,,,,,,,,194013601,1,HIV infection
19401365,194013651,1,I,,20210531,20210611,20210611,EXP,,ET-AUROBINDO-AUR-APL-2021-023223,AUROBINDO,,49,YR,,M,Y,,,20210611,,HP,SE,ET,EFAVIRENZ.,Drug-induced liver injury,194013651,OT,,,,,,,,,194013651,1,HIV infection
19402851,194028511,1,I,,20210531,20210611,20210611,EXP,,ET-AUROBINDO-AUR-APL-2021-023211,AUROBINDO,,45,YR,,F,Y,,,20210611,,HP,ET,ET,EFAVIRENZ.,Cholestatic liver injury,194028511,OT,,,,,,,,,194028511,1,HIV infection
19405275,194052751,1,I,2019,20210603,20210611,20210611,EXP,,DK-MYLANLABS-2021M1034088,MYLAN,"GYNTHERSEN RMM, MENS H, WEGENER M, WAREHAM NE. INTRACRANIAL HYPERTENSION AND PAPILLOEDEMA AS A COMPLICATION TO LOW ANTIRETROVIRAL THERAPY ADHERENCE IN A MAN LIVING WITH CHRONIC HIV. BMJ?CASE?REP 2021?14(3):E237504.",61,YR,,M,Y,,,20210611,,MD,DK,DK,EFAVIRENZ.,Intracranial pressure increased;Leukocytosis;Macular oedema;Optic disc haemorrhage;Papilloedema;Pleocytosis;Retinal exudates;Retroviral rebound syndrome;Visual field defect,194052751,HO,,,194052751,1,2015,,,,194052751,1,HIV infection
19406684,194066841,1,I,2019,20210603,20210611,20210611,EXP,,DK-STRIDES ARCOLAB LIMITED-2021SP006368,STRIDES,"GYNTHERSEN RMM, MENS H, WEGENER M, WAREHAM NE. INTRACRANIAL HYPERTENSION AND PAPILLOEDEMA AS A COMPLICATION TO LOW ANTIRETROVIRAL THERAPY ADHERENCE IN A MAN LIVING WITH CHRONIC HIV. BMJ?CASE?REP. 2021?14(3):E237504",61,YR,,M,Y,,,20210611,,HP,DK,DK,EFAVIRENZ.,Retroviral rebound syndrome;Treatment noncompliance,194066841,HO,,,,,,,,,194066841,1,HIV infection
19407002,194070021,1,I,,20210607,20210611,20210611,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-055680,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210611,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194070021,OT,,,,,,,,,194070021,1,Product used for unknown indication
19407021,194070211,1,I,,20210607,20210611,20210611,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-055687,BRISTOL MYERS SQUIBB,,54,YR,,M,Y,,,20210611,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194070211,OT,,,,,,,,,194070211,1,HIV infection
19408488,194084881,1,I,,20210531,20210612,20210612,EXP,,GB-AUROBINDO-AUR-APL-2021-023300,AUROBINDO,,25,YR,,M,Y,,,20210612,,HP,GB,GB,EFAVIRENZ.,Vanishing bile duct syndrome,194084881,HO,,,,,,,,,194084881,1,Product used for unknown indication
19408489,194084891,1,I,,20210531,20210612,20210612,EXP,,ET-AUROBINDO-AUR-APL-2021-023224,AUROBINDO,,38,YR,,F,Y,,,20210612,,HP,SE,ET,EFAVIRENZ.,Mixed liver injury,194084891,OT,,,,,,,,,194084891,1,HIV infection
19408490,194084901,1,I,,20210531,20210612,20210612,EXP,,ET-AUROBINDO-AUR-APL-2021-023206,AUROBINDO,,25,YR,,M,Y,,,20210612,,HP,SE,ET,EFAVIRENZ.,Drug-induced liver injury,194084901,OT,,,,,,,,,194084901,1,HIV infection
19408491,194084911,1,I,,20210531,20210612,20210612,EXP,,ET-AUROBINDO-AUR-APL-2021-023208,AUROBINDO,,37,YR,,F,Y,,,20210612,,HP,ET,ET,EFAVIRENZ.,Cholestatic liver injury,194084911,OT,,,,,,,,,194084911,1,HIV infection
19408495,194084951,1,I,,20210531,20210612,20210612,EXP,,ET-AUROBINDO-AUR-APL-2021-023207,AUROBINDO,,28,YR,,F,Y,,,20210612,,HP,SE,ET,EFAVIRENZ.,Cholestatic liver injury,194084951,OT,,,,,,,,,194084951,1,HIV infection
19408497,194084971,1,I,,20210531,20210612,20210612,EXP,,ET-AUROBINDO-AUR-APL-2021-023204,AUROBINDO,,34,YR,,F,Y,,,20210612,,HP,SE,ET,EFAVIRENZ.,Cholestatic liver injury,194084971,OT,,,,,,,,,194084971,1,HIV infection
19408501,194085011,1,I,,20210531,20210612,20210612,EXP,,ET-AUROBINDO-AUR-APL-2021-023213,AUROBINDO,,60,YR,,M,Y,,,20210612,,HP,ET,ET,EFAVIRENZ.,Cholestatic liver injury,194085011,OT,,,,,,,,,194085011,1,Product used for unknown indication
19408509,194085091,1,I,,20210531,20210612,20210612,EXP,,ET-AUROBINDO-AUR-APL-2021-023222,AUROBINDO,,31,YR,,M,Y,,,20210612,,HP,SE,ET,EFAVIRENZ.,Mixed liver injury,194085091,OT,,,,,,,,,194085091,1,HIV infection
19410348,194103481,1,I,,20210531,20210614,20210614,EXP,,ET-AUROBINDO-AUR-APL-2021-023221,AUROBINDO,,30,YR,,F,Y,,,20210614,,HP,SE,ET,EFAVIRENZ.,Mixed liver injury,194103481,OT,,,,,,,,,194103481,1,HIV infection
19413580,194135801,1,I,,20210607,20210614,20210614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-055982,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20210614,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194135801,HO,,,,,,,,,194135801,1,Product used for unknown indication
19414929,194149291,1,I,,20210608,20210614,20210614,EXP,,GB-MYLANLABS-2021M1034524,MYLAN,,65,YR,,M,Y,,,20210614,,CN,GB,GB,EFAVIRENZ.,Renal impairment,194149291,OT,,,194149291,1,20120601,,,,194149291,1,HIV infection
19415611,194156111,1,I,,20210607,20210614,20210614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-055685,BRISTOL MYERS SQUIBB,,52,YR,,M,Y,,,20210614,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Diplopia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Progressive external ophthalmoplegia,194156111,OT,,,,,,,,,194156111,1,HIV infection
19417864,194178641,1,I,,20210518,20210615,20210615,EXP,,CN-GILEAD-2021-0532868,GILEAD,ZHENG W?ZHANG W?TANG H?ZHAO D?FENG Y. RENAL FUNCTION OF HIV/AIDS PATIENTS TREATED WITH TENOFOVIR AND ITS INFLUENCING FACTORS IN HUBEI PROVINCE. SOUTH CHINA J PREV MED. 2021?47(4):426?430. DOI:10.12183/J.SCJPM.2021.0426,,,A,,Y,,,20210615,,HP,CN,CN,EFAVIRENZ.,Chronic kidney disease,194178641,OT,,,194178641,1,20150101,20170930,,,194178641,1,HIV infection
19418003,194180031,1,I,,20210610,20210615,20210615,EXP,,CN-GILEAD-2021-0535563,GILEAD,ZHENG W?ZHANG W?TANG H?ZHAO D?FENG Y. RENAL FUNCTION OF HIV/AIDS PATIENTS TREATED WITH TENOFOVIR AND ITS INFLUENCING FACTORS IN HUBEI PROVINCE. SOUTH CHINA J PREV MED.. 2021?47(4):426?430. DOI:10.12183/J.SCJPM.2021.0426,,,A,,Y,,,20210615,,HP,CN,CN,EFAVIRENZ.,Blood creatinine abnormal;Chronic kidney disease,194180031,OT,,,,,,,,,194180031,1,HIV infection
19419932,194199321,1,I,,20210518,20210615,20210615,EXP,,CN-GILEAD-2021-0531381,GILEAD,"ZHENG W, ZHANG W, TANG H, ZHAO D, FENG Y. RENAL FUNCTION OF HIV/AIDS PATIENTS TREATED WITH TENOFOVIR AND ITS INFLUENCING FACTORS IN HUBEI PROVINCE. SOUTH CHINA J PREV MED.. 2021?47(4):426?430. DOI:10.12183/J.SCJPM.2021.0426",,,A,,Y,,,20210615,,HP,CN,CN,EFAVIRENZ.,Chronic kidney disease,194199321,OT,,,194199321,1,20150101,20170930,,,194199321,1,HIV infection
19422072,194220721,1,I,2019,20210603,20210616,20210616,EXP,,DK-LUPIN PHARMACEUTICALS INC.-2021-09481,LUPIN,,61,YR,,M,Y,,,20210616,,HP,DK,DK,EFAVIRENZ.,Intracranial pressure increased;Leukocytosis;Macular oedema;Optic disc haemorrhage;Papilloedema;Pleocytosis;Retinal exudates;Retroviral rebound syndrome;Visual field defect,194220721,HO,,,194220721,1,2015,,,,194220721,1,HIV infection
19422209,194222092,2,F,,20210609,20210616,20210616,EXP,,GB-ABBVIE-21K-167-3948768-00,ABBVIE,,61,YR,,M,Y,,,20210616,,MD,GB,GB,EFAVIRENZ.,Renal impairment,194222092,OT,,,194222092,1,20121101,,,,194222092,1,HIV infection
19425158,194251582,2,F,,20210619,20210616,20210625,EXP,,GB-ABBVIE-21K-167-3948725-00,ABBVIE,,76,YR,,M,Y,,,20210625,,HP,GB,GB,EFAVIRENZ.,Renal impairment,194251582,OT,,,194251582,1,20121101,,,,194251582,1,HIV infection
19425942,194259421,1,I,,20210606,20210617,20210617,EXP,,GB-AUROBINDO-AUR-APL-2021-024731,AUROBINDO,,62,YR,,M,Y,,,20210617,,CN,GB,GB,EFAVIRENZ.,Renal impairment,194259421,OT,,,194259421,1,20150301,,,,194259421,1,HIV infection
19426212,194262121,1,I,,20210611,20210616,20210616,EXP,,GB-MYLANLABS-2021M1035494,MYLAN,,76,YR,,M,Y,,,20210616,,CN,GB,GB,EFAVIRENZ.,Renal impairment,194262121,OT,,,194262121,1,20121101,,,,194262121,1,HIV infection
19426412,194264121,1,I,,20210609,20210616,20210616,EXP,,ES-MYLANLABS-2021M1034815,MYLAN,"ARAGON?S EROLES AM, SCHOENENBERGER ARNAIZ JA, CANOMARR?N SM, PUIG GANAU T, MORALES PORTILLO A, MANONELLES FERN?NDEZ A. RELACI?N ENTRE NIVELES PLASM?TICOS DE EFAVIRENZ Y ALTERACIONES LIP?MICAS. REV.OFIL?ILAPHAR. 2021?31 (1):64?69",,,A,,Y,,,20210616,,MD,ES,ES,EFAVIRENZ.,Hypertension;Thrombosis,194264121,OT,,,,,,,,,194264121,1,Antiretroviral therapy
19426431,194264311,1,I,,20210609,20210616,20210616,EXP,,ES-MYLANLABS-2021M1034808,MYLAN,"ARAGONES EROLES, AM ET AL.. RELACION ENTRE NIVELES PLASMATICOS DE EFAVIRENZ Y ALTERACIONES LIPEMICAS.. REV.OFIL?ILAPHAR. 2021?31 (1):64?69",,,A,,Y,,,20210616,,MD,ES,ES,EFAVIRENZ.,Hypertension;Thrombosis,194264311,OT,,,,,,,,,194264311,1,Antiretroviral therapy
19426441,194264411,1,I,,20210609,20210616,20210616,EXP,,ES-MYLANLABS-2021M1034817,MYLAN,"ARAGON?S EROLES, AM ET AL.. RELACI?N ENTRE NIVELES PLASM?TICOS DE EFAVIRENZ Y ALTERACIONES LIP?MICAS. REV.OFIL?ILAPHAR. 2021?31 (1):64?69",,,A,,Y,,,20210616,,MD,ES,ES,EFAVIRENZ.,Thrombosis,194264411,OT,,,,,,,,,194264411,1,Antiretroviral therapy
19426505,194265051,1,I,,20210609,20210616,20210616,EXP,,ES-MYLANLABS-2021M1034836,MYLAN,"ARAGON?S EROLES, AM ET AL. RELACI?N ENTRE NIVELES PLASM?TICOS DE EFAVIRENZ Y ALTERACIONES LIP?MICAS. REV.OFIL?ILAPHAR. 2021?31 (1):64?69",,,A,,Y,,,20210616,,MD,ES,ES,EFAVIRENZ.,Thrombosis,194265051,OT,,,,,,,,,194265051,1,Antiretroviral therapy
19426507,194265071,1,I,,20210609,20210616,20210616,EXP,,ES-MYLANLABS-2021M1034837,MYLAN,"ARAGONES EROLES, AM ET AL.. RELACION ENTRE NIVELES PLASMATICOS DE EFAVIRENZ Y ALTERACIONES LIPEMICAS. REV.OFIL?ILAPHAR. 2021?31(1):64?69",,,A,,Y,,,20210616,,MD,ES,ES,EFAVIRENZ.,Acute myocardial infarction,194265071,OT,,,,,,,,,194265071,1,Antiretroviral therapy
19426520,194265201,1,I,,20210609,20210616,20210616,EXP,,ES-MYLANLABS-2021M1034838,MYLAN,"ARAGONES EROLES, AM ET AL.. RELACION ENTRE NIVELES PLASMATICOS DE EFAVIRENZ Y ALTERACIONES LIPEMICAS. REV.OFIL?ILAPHAR. 2021?31(1):64?69",,,A,,Y,,,20210616,,MD,ES,ES,EFAVIRENZ.,Acute myocardial infarction,194265201,OT,,,,,,,,,194265201,1,Antiretroviral therapy
19426533,194265331,1,I,,20210609,20210616,20210616,EXP,,ES-MYLANLABS-2021M1034839,MYLAN,"ARAGONES EROLES, AM ET AL.. RELACION ENTRE NIVELES PLASMATICOS DE EFAVIRENZ Y ALTERACIONES LIPEMICAS.. REV.OFIL?ILAPHAR. 2021?31 (1):64?69",,,A,,Y,,,20210616,,MD,ES,ES,EFAVIRENZ.,Acute myocardial infarction,194265331,OT,,,,,,,,,194265331,1,Antiretroviral therapy
19432454,194324541,1,I,,20210607,20210618,20210618,EXP,,US-AUROBINDO-AUR-APL-2021-025023,AUROBINDO,,30,YR,,M,Y,,,20210618,,HP,US,US,EFAVIRENZ.,Acidosis;Circulatory collapse;Coma;Overdose;Renal failure;Shock,194324541,HO,,,,,,,,,194324541,1,Product used for unknown indication
19438156,194381561,1,I,,20210608,20210619,20210619,EXP,,GB-AUROBINDO-AUR-APL-2021-024928,AUROBINDO,,65,YR,,M,Y,,,20210619,,CN,GB,GB,EFAVIRENZ.,Renal impairment,194381561,OT,,,194381561,1,20120601,,,,194381561,1,HIV infection
19439771,194397711,1,I,,20210607,20210620,20210620,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-09731,LUPIN,,38,YR,,,Y,,,20210620,,HP,CN,CN,EFAVIRENZ.,Drug resistance;Liver disorder;Virologic failure,194397711,OT,,,,,,,,,194397711,1,HIV infection
19440343,194403431,1,I,,20210421,20210621,20210621,PER,,US-AUROBINDO-AUR-APL-2021-017166,AUROBINDO,,72,YR,,M,Y,,,20210621,,CN,US,US,EFAVIRENZ TABLETS USP 600MG,Dizziness;Drug hypersensitivity,,,,,194403431,1,,20210427,,,194403431,1,Product used for unknown indication
19441181,194411811,1,I,,20210611,20210621,20210621,EXP,,GB-TEVA-2021-GB-1923736,TEVA,,61,YR,A,M,Y,,,20210621,,MD,GB,GB,EFAVIRENZ.,Renal impairment,194411811,OT,,,194411811,1,20121101,,,,194411811,1,HIV infection
19443164,194431641,1,I,,20210611,20210621,20210621,EXP,,GB-MACLEODS PHARMA UK LTD-MAC2021031584,MACLEODS,,,,,,Y,,,20210621,,CN,GB,GB,EFAVIRENZ.,Renal impairment,194431641,OT,,,194431641,1,20121101,,,,194431641,1,HIV infection
19443903,194439031,1,I,,20210608,20210621,20210621,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-056478,BRISTOL MYERS SQUIBB,,65,YR,,M,Y,,,20210621,,MD,GB,GB,EFAVIRENZ.,Renal impairment,194439031,OT,,,194439031,1,20120601,,,,194439031,1,HIV infection
19445434,194454341,1,I,,20210610,20210622,20210622,EXP,,US-AUROBINDO-AUR-APL-2021-025301,AUROBINDO,,14,YR,,M,Y,,,20210622,,MD,US,US,EFAVIRENZ.,Acute kidney injury;Immune reconstitution inflammatory syndrome associated tuberculosis,194454341,HO,,,,,,,,,194454341,1,HIV infection
19445505,194455051,1,I,,20210611,20210622,20210622,EXP,,GB-AUROBINDO-AUR-APL-2021-025556,AUROBINDO,,61,YR,,M,Y,,,20210622,,CN,GB,GB,EFAVIRENZ.,Renal impairment,194455051,OT,,,194455051,1,20121101,,,,194455051,1,HIV infection
19445667,194456671,1,I,2016,20210614,20210622,20210622,EXP,,LV-VIIV HEALTHCARE LIMITED-LV2021EME131017,VIIV,,57,YR,,M,Y,,,20210621,,CN,LV,LV,EFAVIRENZ.,Depression;Disease recurrence;Neurosyphilis,194456671,OT,,,194456671,1,2016,,,,194456671,1,HIV infection
19445668,194456681,1,I,,20210614,20210622,20210622,EXP,,LV-VIIV HEALTHCARE LIMITED-LV2021EME131019,VIIV,,41,YR,,M,Y,,,20210621,,CN,LV,LV,EFAVIRENZ.,Dizziness;Hyperlipidaemia;Nightmare;Pulmonary hypertension,194456681,OT,,,,,,,,,194456681,1,HIV infection
19445690,194456901,1,I,,20210614,20210622,20210622,EXP,,LV-GLAXOSMITHKLINE-LV2021EME131019,GLAXOSMITHKLINE,,41,YR,,M,Y,,,20210621,,CN,LV,LV,EFAVIRENZ.,Dizziness;Hyperlipidaemia;Nightmare;Pulmonary hypertension,194456901,OT,,,,,,,,,194456901,1,HIV infection
19445706,194457061,1,I,2016,20210614,20210622,20210622,EXP,,LV-GLAXOSMITHKLINE-LV2021EME131017,GLAXOSMITHKLINE,,57,YR,,M,Y,,,20210621,,CN,LV,LV,EFAVIRENZ.,Depression;Disease recurrence;Neurosyphilis,194457061,OT,,,194457061,1,2016,,,,194457061,1,HIV infection
19452098,194520981,1,I,,20210611,20210623,20210623,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-057798,BRISTOL MYERS SQUIBB,,61,YR,,M,Y,,,20210623,,MD,GB,GB,EFAVIRENZ;EMTRICITABINE;TENOFOVIR DISOPROXIL,Renal impairment,194520981,OT,,,194520981,1,20121101,,,,194520981,1,HIV infection
19453005,194530051,1,I,2019,20210614,20210623,20210623,EXP,,DK-TEVA-2021-DK-1924465,TEVA,"GYNTHERSEN RMM, MENS H, WEGENER M, WAREHAM NE. INTRACRANIAL HYPERTENSION AND PAPILLOEDEMA AS A COMPLICATION TO LOW ANTIRETROVIRAL THERAPY ADHERENCE IN A MAN LIVING WITH CHRONIC HIV. BMJ?CASE?REP 2021?14(3):E237504.",61,YR,A,M,Y,,,20210623,,MD,DK,DK,EFAVIRENZ.,Intracranial pressure increased;Leukocytosis;Macular oedema;Optic disc haemorrhage;Papilloedema;Pleocytosis;Retinal exudates;Retroviral rebound syndrome;Visual field defect,194530051,HO,,,194530051,1,2015,,,,194530051,1,HIV infection
19455704,194557041,1,I,,20210622,20210624,20210624,EXP,,GB-ABBVIE-21K-167-3963521-00,ABBVIE,,61,YR,,M,Y,,,20210623,,HP,GB,GB,EFAVIRENZ.,Renal impairment,194557041,OT,,,194557041,1,20121101,,,,194557041,1,HIV infection
19456731,194567311,1,I,,20210609,20210624,20210624,PER,,GB-HORMOSAN PHARMA GMBH-2021-10051,LUPIN,,65,YR,,M,Y,,,20210624,,CN,GB,GB,EFAVIRENZ.,Renal impairment,194567311,OT,,,194567311,1,20120601,,,,194567311,1,HIV infection
19461015,194610151,1,I,,20210617,20210625,20210625,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-059444,BRISTOL MYERS SQUIBB,"ARAGONES EROLES AM, SCHOENENBERGER ARNAIZ JA, CANO MARRON SM, PUIG GANAU T, MORALES PORTILLO A, MANONELLES FERNONDEZ A. RELACION ENTRE NIVELES PLASMATICOS DE EFAVIRENZ Y ALTERACIONES LIPEMICAS. REV.OFIL.ILAPHAR. 2021?31(1):64?9",,,A,,Y,,,20210625,,MD,ES,ES,EFAVIRENZ.,Hypertension;Thrombosis,194610151,OT,,,,,,,,,194610151,1,Antiretroviral therapy
19461093,194610931,1,I,,20210617,20210625,20210625,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-059435,BRISTOL MYERS SQUIBB,"ARAGONES EROLES AM, SCHOENENBERGER ARNAIZ JA, CANOMARRON SM, PUIG GANAU T, MORALES PORTILLO A, MANONELLES FERNANDEZ A. RELACION ENTRE NIVELES PLASMATICOS DE EFAVIRENZ Y ALTERACIONES LIPEMICAS. REV.OFIL.ILAPHAR. 2021?31(1):64?9",,,A,,Y,,,20210625,,MD,ES,ES,EFAVIRENZ.,Hypertension;Thrombosis,194610931,OT,,,,,,,,,194610931,1,Antiretroviral therapy
19463036,194630361,1,I,,20210624,20210625,20210625,EXP,,CA-ASTRAZENECA-2021A562852,ASTRAZENECA,,,,,M,Y,,,20210625,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194630361,DE,,,,,,,,,194630361,1,Product used for unknown indication
19463092,194630921,1,I,,20210624,20210625,20210625,EXP,,CA-ASTRAZENECA-2021A562850,ASTRAZENECA,,,,,M,Y,,,20210625,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194630921,DE,,,,,,,,,194630921,1,Product used for unknown indication
19463312,194633121,1,I,,20210624,20210625,20210625,EXP,,CA-ASTRAZENECA-2021A562828,ASTRAZENECA,,54,YR,,M,Y,,,20210625,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194633121,DE,,,,,,,,,194633121,1,Bipolar disorder
19464464,194644642,2,F,,20210617,20210626,20210626,EXP,,ES-AUROBINDO-AUR-APL-2021-026743,AUROBINDO,,,,A,,Y,,,20210626,,HP,ES,ES,EFAVIRENZ.,Acute myocardial infarction,194644642,OT,,,,,,,,,194644642,1,Antiretroviral therapy
19464465,194644652,2,F,,20210617,20210626,20210626,EXP,,ES-AUROBINDO-AUR-APL-2021-026748,AUROBINDO,,,,A,,Y,,,20210626,,HP,ES,ES,EFAVIRENZ.,Hypertension;Thrombosis,194644652,OT,,,,,,,,,194644652,1,Antiretroviral therapy
19464466,194644662,2,F,,20210617,20210626,20210626,EXP,,ES-AUROBINDO-AUR-APL-2021-026752,AUROBINDO,,,,A,,Y,,,20210626,,HP,ES,ES,EFAVIRENZ.,Hypertension;Thrombosis,194644662,OT,,,,,,,,,194644662,1,Antiretroviral therapy
19465057,194650571,1,I,,20210617,20210627,20210627,EXP,,ES-AUROBINDO-AUR-APL-2021-026744,AUROBINDO,ARAGON?S EROLES AM ET AL.. RELACI?N ENTRE NIVELES PLASM?TICOS DE EFAVIRENZ Y ALTERACIONES LIP?MICAS.. REV.OFIL?ILAPHAR. 2021?31(1):64?69,,,A,,Y,,,20210627,,MD,ES,ES,EFAVIRENZ.,Thrombosis,194650571,OT,,,,,,,,,194650571,1,Antiretroviral therapy
19466507,194665071,1,I,,20210617,20210628,20210628,EXP,,ES-AUROBINDO-AUR-APL-2021-026747,AUROBINDO,"ARAGON?S EROLES, AM ET AL.. RELACI?N ENTRE NIVELES PLASM?TICOS DE EFAVIRENZ Y ALTERACIONES LIP?MICAS.. REV.OFIL?ILAPHAR.. 2021?31(1):64?69.",,,A,,Y,,,20210628,,MD,ES,ES,EFAVIRENZ.,Thrombosis,194665071,OT,,,,,,,,,194665071,1,Antiretroviral therapy
19466697,194666972,2,F,,20210616,20210628,20210630,EXP,,NG-CIPLA LTD.-2021NG04367,CIPLA,,,,,,Y,,,20210630,,HP,NG,NG,EFAVIRENZ.,Foetal exposure during pregnancy;Hydranencephaly,194666972,OT,,,,,,,,,,,
19467017,194670171,1,I,,20210624,20210628,20210628,EXP,,CA-ASTRAZENECA-2021A562847,ASTRAZENECA,,,,,M,Y,,,20210628,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194670171,DE,,,,,,,,,194670171,1,Product used for unknown indication
19469199,194691991,1,I,2016,20210623,20210628,20210628,EXP,,LV-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-062115,BRISTOL MYERS SQUIBB,,57,YR,,M,Y,,,20210628,,MD,LV,LV,EFAVIRENZ.,Depression;Disease recurrence;Neurosyphilis,194691991,OT,,,194691991,1,2016,,,,194691991,1,HIV infection
19469864,194698641,1,I,,20090923,20210629,20210629,EXP,,ZA-AUROBINDO-AUR-APL-2009-00718,AUROBINDO,REACTIONS WEEKLY. 2009?1270:7?8,11,YR,,F,Y,,,20210629,,HP,ZA,ZA,EFAVIRENZ.,Agitation;Confusional state;Delirium;Delusion;Dementia;Depression;General physical health deterioration;Hallucination;Hemiplegia;Intracranial pressure increased;Meningitis tuberculous;Mood altered,194698641,DE,,,,,,,,,194698641,1,HIV infection
19469931,194699311,1,I,,20210616,20210629,20210629,EXP,,BR-CIPLA LTD.-2021BR04496,CIPLA,,,,,,Y,,,20210629,,HP,US,BR,EFAVIRENZ.;EFAVIRENZ/LAMIVUDINE/TENOFOVIR,Foetal exposure during pregnancy;Low birth weight baby;Premature baby,194699311,OT,,,,,,,,,,,
19469985,194699851,1,I,,20210617,20210628,20210628,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-059445,BRISTOL MYERS SQUIBB,"ARAGONES EROLES AM, SCHOENENBERGER ARNAIZ JA, CANO MARRON SM, GANAU TP, MORALES PORTILLO A, FERNANDEZ AM. RELACION ENTRE NIVELES PLASMATICOS DE EFAVIRENZ Y ALTERACIONES LIPEMICAS. REV.OFIL.LLAPHAR. 2021?31(1):64?9",,,A,,Y,,,20210628,,MD,ES,ES,EFAVIRENZ.,Thrombosis,194699851,OT,,,,,,,,,194699851,1,Antiretroviral therapy
19470007,194700071,1,I,,20210519,20210628,20210628,EXP,,IT-GILEAD-2021-0537622,GILEAD,,36,YR,A,M,Y,,,20210628,,HP,IT,IT,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Genotype drug resistance test positive,194700071,OT,,,,,,,,,194700071,1,HIV infection
19470019,194700191,1,I,,20210617,20210629,20210629,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-059448,BRISTOL MYERS SQUIBB,"ARAGONES EROLES AM, SCHOENENBERGER ARNAIZ JA, CANO MARRON SM, PUIG GANAU T, MORALES PORTILLO A, MANONELLES FERNONDEZ A. RELACION ENTRE NIVELES PLASMATICOS DE EFAVIRENZ Y ALTERACIONES LIPEMICAS. REV.OFIL.ILAPHAR. 2021?31(1):64?9",,,A,,Y,,,20210629,,MD,ES,ES,EFAVIRENZ.,Acute myocardial infarction,194700191,OT,,,,,,,,,194700191,1,Antiretroviral therapy
19470053,194700531,1,I,,20210519,20210628,20210628,EXP,,IT-GILEAD-2021-0537627,GILEAD,,52,YR,A,F,Y,,,20210628,,HP,IT,IT,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Genotype drug resistance test positive,194700531,OT,,,,,,,,,194700531,1,HIV infection
19470549,194705491,1,I,,20210621,20210628,20210628,EXP,,CA-BAUSCH-BL-2021-022005,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210628,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194705491,DE,,,,,,,,,194705491,1,Bipolar disorder
19470552,194705521,1,I,,20210621,20210628,20210628,EXP,,CA-BAUSCH-BL-2021-022006,BAUSCH AND LOMB,,,,,M,Y,,,20210628,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194705521,DE,,,,,,,,,194705521,1,Product used for unknown indication
19470553,194705531,1,I,,20210621,20210628,20210628,EXP,,CA-BAUSCH-BL-2021-022007,BAUSCH AND LOMB,,,,,M,Y,,,20210628,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194705531,OT,,,,,,,,,194705531,1,Product used for unknown indication
19470558,194705581,1,I,,20210621,20210628,20210628,EXP,,CA-BAUSCH-BL-2021-022004,BAUSCH AND LOMB,,,,,M,Y,,,20210628,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194705581,OT,,,,,,,,,194705581,1,Product used for unknown indication
19470570,194705701,1,I,,20210621,20210628,20210628,EXP,,CA-BAUSCH-BL-2021-022009,BAUSCH AND LOMB,,,,,M,Y,,,20210628,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194705701,DE,,,,,,,,,194705701,1,Product used for unknown indication
19471162,194711621,1,I,,20210621,20210628,20210628,EXP,,CA-BAUSCH-BL-2021-022011,BAUSCH AND LOMB,,54,YR,,M,Y,,,20210628,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,194711621,OT,,,,,,,,,194711621,1,Bipolar disorder
19472067,194720671,1,I,,20081215,20210629,20210629,EXP,,US-AUROBINDO-08-AUR-06867,AUROBINDO,,40,YR,,M,Y,,,20210629,,HP,US,US,EFAVIRENZ.,Apoptosis;Hepatic steatosis;Hepatotoxicity;Lipodystrophy acquired;Liver function test abnormal,194720671,OT,,,,,,,,,194720671,1,HIV infection
19472123,194721231,1,I,,20090923,20210629,20210629,EXP,,ZA-AUROBINDO-AUR-APL-2009-00715,AUROBINDO,,9,YR,,F,Y,16,KG,20210629,,MD,ZA,ZA,EFAVIRENZ.,"Agitation;Anxiety;Apathy;Confusional state;Delirium;Depression;Disinhibition;Euphoric mood;Fear;Feeling abnormal;Hallucinations, mixed;Lethargy;Nightmare;Poor quality sleep;Social avoidant behaviour",194721231,OT,,,,,,,,,194721231,1,HIV infection
19472747,194727471,1,I,,20210617,20210629,20210629,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-059414,BRISTOL MYERS SQUIBB,"ARAGONES EROLES AM,SCHOENENBERGER ARNAIZ JA, CANO MARRON SM, GANAU TP, MORALES PORTILLO A, FERNANDEZ AM. RELACION ENTRE NIVELES PLASMATICOS DE EFAVIRENZ Y ALTERACIONES LIPEMICAS. REV.OFIL?ILAPHAR. 2021?31(1):64?9",,,A,,Y,,,20210629,,MD,ES,ES,EFAVIRENZ.,Thrombosis,194727471,OT,,,,,,,,,194727471,1,Antiretroviral therapy
19476449,194764491,1,I,20190315,20210616,20210630,20210630,EXP,,BR-CIPLA LTD.-2021BR04414,CIPLA,,,,,,Y,,,20210630,,HP,US,BR,EFAVIRENZ.;EFAVIRENZ/LAMIVUDINE/TENOFOVIR,Exposure during pregnancy;Premature delivery,194764491,OT,,,,,,,,,194764491,1,Antiretroviral therapy
19478851,194788511,1,I,,20210618,20210630,20210630,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-060288,BRISTOL MYERS SQUIBB,"ARAGONES EROLES AM, SCHOENENBERGER ARNAIZ JA, CANO MARRON SM, PUIG GANAU T, MORALES PORTILLO A, MANONELLES FERNANDEZ A. RELACION ENTRE NIVELES PLASMATICOS DE EFAVIRENZ Y ALTERACIONES LIPEMICAS. REV.OFIL.ILAPHAR. 2021?31(1):64?9",,,A,,Y,,,20210630,,MD,ES,ES,EFAVIRENZ.,Acute myocardial infarction,194788511,OT,,,,,,,,,194788511,1,Antiretroviral therapy
19478889,194788891,1,I,,20210618,20210630,20210630,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-060299,BRISTOL MYERS SQUIBB,"ARAGONES EROLES AM, SCHOENENBERGER ARNAIZ JA, CANO MARRON SM, PUIG GANAU T, MORALES PORTILLO A, MANONELLES FERNANDEZ A. RELACION ENTRE NIVELES PLASMATICOS DE EFAVIRENZ Y ALTERACIONES LIPEMICAS. REV.OFIL.ILAPHAR. 2021?31(1):64?9",,,A,,Y,,,20210630,,MD,ES,ES,EFAVIRENZ.,Acute myocardial infarction,194788891,OT,,,,,,,,,194788891,1,Antiretroviral therapy
6753908,67539089,9,F,20060602,20210615,20080911,20210629,EXP,,CA-MERCK-0809CAN00002,MERCK,,44,YR,,M,Y,,,20210629,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,67539089,HO,,,67539089,1,20070626,20070522,,,67539089,1,HIV infection
7057071,70570713,3,F,,20210609,20090722,20210618,EXP,,CA-JNJFOC-20090704890,JOHNSON AND JOHNSON,"PFEFFIER G, COTE H, MONTANNER J, LI C, JITRATKOSOL M, MEZEI M. OPHTHALMOPLEGIA AND PTOSIS: MITOCHONDRAIL TOXICITY IN PATIENTS RECEIVING HIV THERAPY.. NUEROLOGY 73 2009?1:P71?72.",52,YR,A,M,Y,,,20210618,,MD,CA,CA,EFAVIRENZ.,Progressive external ophthalmoplegia,70570713,OT,,,70570713,3,200802,,,,70570713,1,HIV infection
7152253,715225313,13,F,,20210217,20091019,20210512,EXP,,CA-PFIZER INC-2009279889,PFIZER,"PFEFFER, G.. OPHTHALMOPLEGIA AND PTOSIS: MITOCHONDRIAL TOXICITY IN PATIENTS RECEIVING HIV THERAPY. NEUROLOGY. 2009?73 (1):71?72",52,YR,,M,Y,,,20210512,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Diplopia;Extraocular muscle paresis;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia;Progressive external ophthalmoplegia,715225313,OT,,,,,,,,,715225313,1,HIV infection
7302622,730262237,37,F,,20210420,20100302,20210428,EXP,,CA-MERCK-0907CAN00093,MERCK,,52,YR,,M,Y,,,20210428,,HP,CA,CA,EFAVIRENZ.;SUSTIVA,Blood lactic acid increased;Diplopia;Dysphagia;Extraocular muscle paresis;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia;Progressive external ophthalmoplegia,730262237,OT,,,730262237,10,200802,,,,730262237,1,HIV infection
8443574,84435742,2,F,,20210412,20120306,20210423,EXP,,NG-BRISTOL-MYERS SQUIBB COMPANY-16428351,BRISTOL MYERS SQUIBB,"OGOINA D, ADEKUNLE V, OBIAKO R, UMAR A, AKOLAWOLE M, OVOSI J. DISSEMINATED INFECTIONS DUE TO IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AFTER HIGHLY ACTIVE ANTIRETROVIRAL THERAPY REPORT OF 3 CASES FROM NIGERIA. PAN AFRICAN MEDICAL JOURNAL. 2011?9(38):1?5",19,YR,,F,Y,,,20210423,,HP,NG,NG,EFAVIRENZ.,Immune reconstitution inflammatory syndrome;Kaposi's sarcoma,84435742,DE,,,,,,,,,84435742,1,HIV infection
9574930,95749303,3,F,201007,20210615,20131001,20210623,EXP,,CA-009507513-1309CAN014543,MERCK,,44,YR,,M,Y,,,20210623,,CN,CA,CA,EFAVIRENZ.,Asthenia;Drug interaction;Drug level increased;Dysarthria;Gait disturbance;Neurotoxicity;Slow speech;Somnolence,95749303,OT,,,95749303,1,200710,200801,,,95749303,1,Antiviral treatment
